Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Subject Index

Identifieur interne : 000300 ( Istex/Corpus ); précédent : 000299; suivant : 000301

Subject Index

Auteurs :

Source :

RBID : ISTEX:06575D9CFA43C3148A6BCDF7138AD5B7E364A5EF
Url:
DOI: 10.1046/j.1365-2133.2002.t01-1-01466.x

Links to Exploration step

ISTEX:06575D9CFA43C3148A6BCDF7138AD5B7E364A5EF

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Subject Index</title>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:06575D9CFA43C3148A6BCDF7138AD5B7E364A5EF</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1046/j.1365-2133.2002.t01-1-01466.x</idno>
<idno type="url">https://api.istex.fr/document/06575D9CFA43C3148A6BCDF7138AD5B7E364A5EF/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000300</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000300</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Subject Index</title>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">British Journal of Dermatology</title>
<title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title>
<idno type="ISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<imprint>
<biblScope unit="vol">146</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1133">1133</biblScope>
<biblScope unit="page" to="1141">1141</biblScope>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-06">2002-06</date>
</imprint>
<idno type="ISSN">0007-0963</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0007-0963</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<keywords>
<teeft>
<json:string>case report</json:string>
<json:string>cutaneous</json:string>
<json:string>dermatitis</json:string>
<json:string>concise communication</json:string>
<json:string>psoriasis</json:string>
<json:string>atopic</json:string>
<json:string>dermatology</json:string>
<json:string>clinical cameo</json:string>
<json:string>receptor</json:string>
<json:string>atopic dermatitis</json:string>
<json:string>keratinocytes</json:string>
<json:string>mutation</json:string>
<json:string>apoptosis</json:string>
<json:string>melanoma</json:string>
<json:string>british journal</json:string>
<json:string>tumour</json:string>
<json:string>dermatologist</json:string>
<json:string>lupus</json:string>
<json:string>british association</json:string>
<json:string>human skin</json:string>
<json:string>epidermal</json:string>
<json:string>concise</json:string>
<json:string>langerhans</json:string>
<json:string>pemphigus</json:string>
<json:string>poster</json:string>
<json:string>cameo</json:string>
<json:string>mouse skin</json:string>
<json:string>carcinoma</json:string>
<json:string>nitric oxide inhibitors</json:string>
<json:string>mutational analysis</json:string>
<json:string>skin cancer</json:string>
<json:string>photodynamic therapy</json:string>
<json:string>syndrome</json:string>
<json:string>yellow nail syndrome</json:string>
<json:string>hypothalamic tumour</json:string>
<json:string>tinea capitis</json:string>
<json:string>diabetes mellitus</json:string>
<json:string>extracorporeal photopheresis</json:string>
<json:string>systemic lupus erythematosus</json:string>
<json:string>actinic keratoses</json:string>
<json:string>granuloma annulare</json:string>
<json:string>antiretroviral therapy</json:string>
<json:string>hacat keratinocytes</json:string>
<json:string>mutation analysis</json:string>
<json:string>basal cell carcinoma</json:string>
<json:string>cutaneous horn</json:string>
<json:string>topical treatment</json:string>
<json:string>blastocystis hominis infection</json:string>
<json:string>itraconazole therapy</json:string>
<json:string>molluscum contagiosum</json:string>
<json:string>therapy</json:string>
<json:string>porphyria cutanea tarda</json:string>
<json:string>generalized pustular</json:string>
<json:string>erythema annulare centrifugum</json:string>
<json:string>head lice</json:string>
<json:string>junctional intercellular communication</json:string>
<json:string>human keratinocytes</json:string>
<json:string>chronic urticaria</json:string>
<json:string>cholesterol embolism</json:string>
<json:string>chondrodermatitis nodularis</json:string>
<json:string>oral therapy</json:string>
<json:string>citric acid treatment</json:string>
<json:string>symptom management programme</json:string>
<json:string>collagen synthesis</json:string>
<json:string>contact dermatitis</json:string>
<json:string>nickel release</json:string>
<json:string>childhood atopic dermatitis</json:string>
<json:string>lesional dithranol therapy</json:string>
<json:string>acute myeloblastic leukaemia</json:string>
<json:string>cutaneous lupus erythematosus</json:string>
<json:string>systemic involvement</json:string>
<json:string>cyclic oligopeptides</json:string>
<json:string>female androgenetic alopecia</json:string>
<json:string>broblast growth factor expression</json:string>
<json:string>steatocystoma multiplex</json:string>
<json:string>varicelliform eruption</json:string>
<json:string>squamous cell carcinoma</json:string>
<json:string>medical students</json:string>
<json:string>patch testing</json:string>
<json:string>vivo microdialysis determination</json:string>
<json:string>objective method</json:string>
<json:string>toenail onychomycosis</json:string>
<json:string>fceria receptor</json:string>
<json:string>peripheral blood</json:string>
<json:string>squamous syringometaplasia</json:string>
<json:string>dermal apoptosis</json:string>
<json:string>breast cancer</json:string>
<json:string>desmosomal adhesion regulation</json:string>
<json:string>epidermodysplasia verruciformis</json:string>
<json:string>antiphospholipid syndrome</json:string>
<json:string>langerhans cell migration</json:string>
<json:string>reuptake inhibitor</json:string>
<json:string>psoriatic arthritis</json:string>
<json:string>extracellular nucleotides</json:string>
<json:string>hacat cells</json:string>
<json:string>mouse model</json:string>
<json:string>langerhans cell</json:string>
<json:string>uoroquinolone antibiotics</json:string>
<json:string>refractory chromoblastomycosis</json:string>
<json:string>gold acupuncture</json:string>
<json:string>alopecia areata</json:string>
<json:string>notch4 gene</json:string>
<json:string>nasal dorsum</json:string>
<json:string>bupropion treatment</json:string>
<json:string>receptor status</json:string>
<json:string>heat shock protein</json:string>
<json:string>sodium lauryl sulphate</json:string>
<json:string>virus infection</json:string>
<json:string>hyaluronic acid injection</json:string>
<json:string>merkel cell carcinoma</json:string>
<json:string>toxic epidermal necrolysis</json:string>
<json:string>ing1 overexpression</json:string>
<json:string>wound healing</json:string>
<json:string>arterial embolization</json:string>
<json:string>lesional skin</json:string>
<json:string>cytotoxic effects</json:string>
<json:string>cell death</json:string>
<json:string>transcriptional regulation</json:string>
<json:string>lactoferrin inhibition</json:string>
<json:string>lentigo maligna</json:string>
<json:string>lentigo maligna melanoma</json:string>
<json:string>attachment variant</json:string>
<json:string>palmoplantar keratoderma</json:string>
<json:string>oral leukoplakia</json:string>
<json:string>lupus anticoagulant</json:string>
<json:string>cutaneous melanocytic lesions</json:string>
<json:string>vaginal lymphorroea</json:string>
<json:string>intestinal lymphangiectasia</json:string>
<json:string>micrographic surgery</json:string>
<json:string>morphoea profunda</json:string>
<json:string>hair extension</json:string>
<json:string>tandem duplications</json:string>
<json:string>pemphigus vulgaris</json:string>
<json:string>natural history</json:string>
<json:string>nfat1 expression</json:string>
<json:string>palmoplantar pustulosis</json:string>
<json:string>pronematus davisi</json:string>
<json:string>long term results</json:string>
<json:string>cell carcinoma</json:string>
<json:string>mtdna deletion</json:string>
<json:string>pemphigus foliaceus</json:string>
<json:string>peripheral blood basophils</json:string>
<json:string>diurnal variation</json:string>
<json:string>cell responses</json:string>
<json:string>dermatological disorders</json:string>
<json:string>multiple warts</json:string>
<json:string>cytokeratin expression</json:string>
<json:string>skin atrophy</json:string>
<json:string>patient satisfaction</json:string>
<json:string>cytoprotective genes</json:string>
<json:string>sodium dodecyl sulphate</json:string>
<json:string>chronic plaque psoriasis</json:string>
<json:string>pyoderma gangrenosum</json:string>
<json:string>subject index</json:string>
<json:string>angiogenic response</json:string>
<json:string>correspondence</json:string>
<json:string>lesion</json:string>
</teeft>
</keywords>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>acanthosis nigricans in pregnancy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>acne</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>antimicrobial therapy (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>P. acnes T‐cell mitogenic activity and inflammation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>prevalence of antibiotic‐resistant propionibacteria in skin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>actinic keratoses</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>role of inflammation in progression to squamous cell carcinoma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>topical treatment with diclofenac in hyaluronan gel</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>acute barrier disruption, impact of anatomical location on recovery</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>acute myeloblastic leukaemia, sterile suppurative folliculitis associated (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>adrenaline, audit of use of self‐administered syringes in angiooedema</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>ageing, effects on TNFα‐induced Langerhans cell migration</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>alopecia, androgenetic</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hairless gene</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>minoxidil versus cyproterone acetate therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>alopecia areata, and notch4 gene (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>α‐melanocyte‐stimulating hormone</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>expression in lesional skin of melasma (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>signalling in HaCaT keratinocytes (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>5‐aminolaevulinic acid, correlation between transdermal delivery and cutaneous protoporphyrin IX accumulation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>amyloidosis, Hungarian‐type familial transthyretin (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>anaphylaxis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>following use of latex as hair extension adhesive (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>food‐dependent exercise‐induced</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>angio‐oedema</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>audit of use of self‐administered adrenaline syringes</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>natural history</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>recurrent, as presenting sign of non‐Hodgkin's B‐cell lymphoma (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>antibiotics, topical, frequency of patch test reactions to</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>anti‐E‐selectin therapy in psoriasis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>anti‐laminin 5 pemphigoid and acquired haemophilia (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>antimicrobial therapy in acne (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>antinuclear antibody induction in female nod mice following UVB irradiation (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>antiphospholipid syndrome, subclinical, effects of sclerotherapy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>antiretroviral therapy, regression of multiple warts in HIV infection following (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>anti‐Ro/SSA antibody induction in female nod mice following UVB irradiation (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Apligraf®, epidermal–dermal interactions and gelatinase activity</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>apoptosis, role in resolution of cutaneous antigen‐specific inflammation (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>arrector pili proximal attachment variant in scalp terminal follicles (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>arterial embolization following hyaluronic acid injection (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>atopic dermatitis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>comparison of short‐use potent versus prolonged‐use mild corticosteroids (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>effect of primary care dermatology nurse consultation on quality of life of children</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>effects of oral persimmon leaf extracts in mouse model and hypertension</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>IL‐10 production by DER p1‐specific T cells (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Langerhans cell expression of FcɛRIα receptor (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>maintenance PUVA therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>objective method to assay itch (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>prevalence and epidemiology in Singapore school children</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>quality of life by body site and effect of patch testing</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Six Area, Six Sign severity score (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>wet wrap dressings (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>ATP2A2 gene, mutation analysis in Darier's disease</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>ATP2C1 gene, mutation analysis in Hailey–Hailey disease</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>basal cell carcinoma and diet</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>expression of sonic hedgehog signal transducer</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>basic fibroblast growth factor expression in familial glomangioma (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Behçet's disease, oral pathergy test (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>β‐tryptase assay and compound screening in human skin (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Bier white spots in cryoglobulinaemia (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Blastocystis hominis infection, hypersensitivy to NSAIDs and chronic urticaria (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Bowen's disease, photodynamic therapy (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>breast cancer</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>mimicked by subcutaneous sarcoidosis (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>and persistent erythematous eyelid swelling (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>bullous pemphigoid, extensive erosive (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>bupropion treatment associated with generalized pustular and erythrodermic psoriasis (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>caeruloplasmin serum level in adult Still's disease (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>calcipotriol</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in erythema annulare centrifugum (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in extragenital lichen sclerosus (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cancer registry, electronic, in district general hospital (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Candida and onychomycosis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>carbaryl resistance in head lice</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>carcinogenesis associated with human papillomaviruses, loss of gap junctional intercellular communication (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>caspase‐1 activity regulation in human keratinocytes (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Castleman's disease, paraneoplastic pemphigus in (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>CCR7 expression in cutaneous antigen‐specific inflammation (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cellulitis, eosinophilic bullous (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cholesterol embolism and venous leg ulcers (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cholesterol embolization syndrome (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>chondrodermatitis nodularis, intralesional triamcinolone therapy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>chromoblastomycosis, vitamin D3 and oral terbinafine therapy (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>chronic renal failure with vegetative pyoderma gangrenosum (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>citric acid treatment of non‐healing ulcers in leprosy (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>clindamycin, cutaneous adverse reactions to</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cognitive–behavioural symptom management programme as adjunct to therapy in psoriasis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>collagenoma, isolated plantar (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>collagen synthesis, effects of smoking on in human skin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>connexin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dominant disorders (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>26 mutation associated with HID and KID syndromes</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>contact dermatitis due to nickel release from the Euro (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cornified cell envelope formation in human hair follicle development</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>corticosteroids</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>comparison of short‐use potent versus prolonged‐use mild in childhood atopic dermatitis (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>topical</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in acute radiation dermatitis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>combination with lesional short‐contact dithranol therapy in psoriasis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cryoglobulinaemia, diffuse Bier white spots in (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cryotherapy, warts (Correspondence) 341 (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cutaneous lupus erythematosus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>human Ro60 (SSA2) genomic organization and sequence alterations</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lymphocytopenia as marker of systemic involvement (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cyclic oligopeptides, effects on T cells (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cyclophilin dynamics (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cyproterone acetate in female androgenetic alopecia</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cytochrome P450 1A1 induction in mouse skin by UVB (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cytokeratin expression</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pilonidal sinus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>steatocystoma multiplex (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Darier's disease</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>ATP2A2 mutation analysis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>genetic epidemiology</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>and Kaposi's varicelliform eruption (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>decay accelerating factor aberrant expression in vitiligo</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Denmark, nickel‐exposure regulation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dermal papilla cell oestrogen receptor expression (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dermatology nurse, effect of primary care consultation on quality of life of children with atopic dermatitis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dermatology teaching to medical students</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dermatoscope, use for early identification of melanoma using three‐colour test (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dermis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>eNOS knockout mouse, apoptosis following UVB irradiation (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in vivo microdialysis determination of IL‐6</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>desmosome adhesion regulation in wounded epidermis (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>diabetes mellitus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>autologous keratinocyte therapy of neuropathic foot ulcers (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>and granuloma annulare (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>terbinafine therapy of toenail onychomycosis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>diclofenac, topical treatment of actinic keratoses</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>diet and basal cell carcinoma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>diphenylcyclopropenone, responses of peripheral blood mononuclear cells to (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dithranol</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>combination of lesional short‐contact therapy with potent topical corticosteroid in psoriasis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>induced tolerance in mouse ear oedema model</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>inflammation induced by, and phenotype (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>inflammatory response to in non‐lesional psoriasis (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>docetaxel</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>association with squamous syringometaplasia (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>nail changes induced by (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>drug allergy, blood test for confirmation (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dyspareunia as sign of recurrence of glucagonoma (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dystrophic epidermolysis bullosa, clinical spectrum</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>eccrine poroma (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>eczema see atopic dermatitis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>EEC syndrome, prenatal diagnosis and p63 gene mutation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>elastin receptor expression in perforating skin disorders</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>eNOS knockout mouse, dermal apoptosis following UVB irradiation (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>epidermal wounds, desmosomal adhesion regulation (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>epidermodysplasia verruciformis with neurofibromatosis type 1 (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Epstein–Barr virus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in blastoid nasal T/natural killer cell lymphoma (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>systemic lupus erythematosus induced by infection (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>erythema</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>facial, effects of nitric oxide inhibitors (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>photo‐inducible mechanisms in clearance (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>UV‐induced, and skin pigmentation (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>erythema annulare centrifugum, calcipotriol therapy (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>erythema migrans, long‐term prognosis following treatment in France (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>erythromelalgia, treatment with serotonin/noradrenaline reuptake inhibitor (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>etanercept</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dermatological complications following therapy for rheumatoid arthritis (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in psoriasis and psoriatic arthritis (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Euro, nickel release and contact dermatitis (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>extracellular nucleotides, effect on HaCaT cells (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>extracorporeal photopheresis, induction of apoptosis in graft‐versus‐host disease and cutaneous T‐cell lymphoma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>eyelid swelling and breast cancer (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>facial telangiectasia, effects of nitric oxide inhibitors (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>FcεRIα receptor expression by Langerhans cell in atopic dermatitis (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>fibrillin‐rich microfibrils, effects of acute UVB irradiation on (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>fibulin‐2 in dermis of photoaged skin (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>fluoroquinolone antibiotics and photosensitization of thymine dimer formation in mouse skin (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>follicular adnexal tumours, differentiation between malignant and benign by DNA damage cytometry</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>follicular hamartoma with acrochordons, seborrhoeic keratoses and chondrosarcoma (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>folliculitis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>with cutaneous larva migrans (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>sterile suppurative, associated with acute myeloblastic leukaemia (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>foot ulcers, diabetic neuropathic, autologous keratinocyte therapy (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>free radicals in antigen formation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>glomangioma, familial, basic fibroblast growth factor expression (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>glucagonoma, brittle nails and dyspareunia as signs of recurrence (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>gold acupuncture, pseudolymphoma induced by (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>graft‐versus‐host disease, induction of apoptosis by extracorporeal photopheresis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>granuloma annulare</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>and diabetes mellitus (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>treatment with a 5‐lipoxygenase inhibitor and vitamin E (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>griseofulvin in tinea capitis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>haemangioma, hobnail, nasal dorsum (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>haematoma as complication of arterial Doppler studies (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>haemophilia, acquired, and anti‐laminin 5 pemphigoid (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Hailey–Hailey disease, ATP2C1 gene mutation analysis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hair</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>darkening in porphyria cutanea tarda (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>density, diameter and female pattern loss (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>growth promotion with procyanidin B‐2</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>melanins and melanocortin 1 receptor status (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hairdressers, skin irritation thresholds</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hair follicles, formation of cornified cell envelope in development</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hairless gene in androgenetic alopecia</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hand dermatitis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hairdressers</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>psychological factors</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>headache, dapsone‐induced, vitamin E therapy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>head lice resistance to pediculocides</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>heart, isolated amelanotic melanoma (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>heat shock protein</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>induction by sodium lauryl sulphate in human skin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>upregulation in skin of patients with keratin gene mutations (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>heat shock protein</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hepatitis C virus infection, cutaneous sarcoidosis during treatment for (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Hermansky–Pudlak syndrome and systemic lupus erythematosus (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>HID syndrome and connexin 26 mutation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>histamine, pruritogenic effects in mice (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>histiocytosis, progressive nodular, with hypothalamic tumour (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>HIV infection</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cutaneous protothecosis in (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>and Merkel cell carcinoma (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>regression of multiple warts following antiretroviral therapy (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>HLA alleles in Japanese pemphigus patients</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hobnail haemangioma of nasal dorsum (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>5‐HT, pruritogenic effects in mice (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>human papillomaviruses</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>carcinogenesis associated, loss of gap junctional intercellular communication (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>type</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hyaluronic acid injection, arterial embolization following (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hydroperoxides, reduction of contact allergic response to by epidermal antioxidant treatment</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hyperhidrosis, mesilate therapy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hypertension and atopic dermatitis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hypothalamic tumour with progressive nodular histiocytosis (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>imiquimod in porokeratosis of Mibelli (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>immune‐based therapies in psoriasis (Review)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>immunotherapy, topical, viral warts (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>infancy, malignant atrophic papulosis (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>inflammation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cutaneous antigen‐specific, CCR7 expression and role of apoptosis in resolution (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dithranol‐induced, and phenotype (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>role in progression of actinic keratoses to squamous cell carcinoma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>infliximab in toxic epidermal necrolysis (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>ING1 overexpression in human melanoma cell lines</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>interleukins</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>IL‐6, in vivo microdialysis determination in human dermis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>IL‐8, effect on HaCaT cells (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>IL‐10</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>inhibition of UVB‐induced expression by selenium compounds (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>production by DER p1‐specific T cells in atopic dermatitis (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>IL‐12, production by cells in mouse skin exposed to S. mansoni (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>iodine, slow release preparations and wound healing</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>iron chelating agents, effects on photodynamic therapy (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>itch</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>experimental, in sodium lauryl sulphate‐inflamed and normal human skin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>objective method to assay in childhood atopic dermatitis (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>itraconazole</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>long term results of therapy in onychomycosis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in yellow nail syndrome (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>ITT (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Kaposi's sarcoma, classic, virological status following chemotherapy/radiotherapy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Kaposi's varicelliform eruption and Darier's disease (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>keratin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>characterization and regulation of type II hair‐specific genes (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>gene mutations and upregulation of small heat shock  protein (Hsp27) (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>keratinocytes</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>abnormal proliferation in molluscum contagiosum</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>autologous therapy in diabetic neuropathic foot ulcers (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cytotoxic effects of photodynamic therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>HaCaT</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>effects of IL‐8 and extracellular nucleotides on (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>inhibition of UVB‐induced apoptosis by NO synthase  antagonists (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>MSH peptide signalling (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>invasion by Staphylococcus aureus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>regulation of caspase‐1 activity (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>selenium‐induced protection from chemical and UVR‐induced cell death (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>transcriptional regulation of activation in wound healing (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>KID syndrome and connexin mutation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Kikuchi's disease and SLE (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lactoferrin inhibition of Langerhans cell migration and TNF‐α production (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>laminin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Langerhans cells</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>effects of ageing on TNF‐α‐induced migration</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>expression of FcɛRIα receptor in atopic dermatitis (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>human epidermal migration and TNF‐α production following suction blister formation (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lactoferrin inhibition of migration and TNF‐α production (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>regulation of migration (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>larva migrans with folliculitis (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>laser capture microdissection of paraffin‐fixed skin sections (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>laser therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>one‐pass resurfacing</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>port‐wine stains</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>latex</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>contact anaphylaxis following use as hair extension adhesive (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>type IV hypersensitivity reactions to</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>leflunomide in severe psoriasis and psoriatic arthritis (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lentigo maligna, radiotherapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lentigo maligna melanoma, radiotherapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>leprosy, citric acid treatment of non‐healing ulcers (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>leukoplakia, oral, with cutaneous horn of the lips and palmoplantar keratoderma (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lichen nitidus, treatment with antituberculous agent (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lichen sclerosus, extragenital, topical calcipotriol therapy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>linear scleroderma, with muscle calcification (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lipomatous mixed tumour of the skin (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lips, cutaneous horn, with oral leukoplakia and palmoplantar keratoderma (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>loratidine, fixed drug eruption due to (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lupus anticoagulant and venous leg ulcers (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lupus erythematosus tumidus, upregulation of epidermal surface molecule expression in UVR‐induced lesions</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lupus vulgaris, diagnosis after 87 years (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lymphangioendothelioma, benign (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lymphocytopenia as marker of systemic involvement in cutaneous lupus erythematosus (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lymphoedema with xanthomatosis, vaginal lymphorroea amd intestinal lymphangiectasia (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lymphoma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>B‐cell, presentation as recurrent angio‐oedema and molluscum contagiosum (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>blastoid nasal T/natural killer cell, Epstein–Barr virus positive (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cutaneous large B‐cell, similarity to chronic venous ulcer (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cutaneous T‐cell</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>CD30+ with concurrent solid tumour (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>induction of apoptosis by extracorporeal photopheresis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lymphoblastoid natural killer‐cell (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>primary cutaneous B‐cell, absence of chromosomal translocation (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>primary subcutaneous follicular centre cell, involvement of the galea (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>T‐zone with cutaneous involvement (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>lymphoma molluscatum (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>male sexual dysfunction and thalidomide (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>malignant atrophic papulosis in infancy (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>mastectomy, granulomatous lesions of homolateral limb following (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>medical students, dermatology teaching practices</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>melanin‐concentrating hormone receptor‐1 in vitiligo (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>melanins, hair, and melanocortin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>melanocortin 1 receptor</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>relationship of status to hair melanins (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>variants in melanoma cells (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>visualization (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>melanoma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>analysis of tumour site in relation to phenotopic traits and epidemiology</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>detection of atypical marginal melanocytes using Mohs' micrographic surgery</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>detection rate, self‐examination and clinical evaluation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>ING1 overexpression in cell lines</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>isolated amelanotic of the heart (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>loss of catenin expression and disease progression (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>melanocortin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>serum S100</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>concentrations and prediction of micrometastatic disease</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>as marker in children (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>tyrosinase, MIA and MART‐1 expression in sentinel lymph nodes</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>UK management guidelines</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>use of dermatoscope for early identification using three‐colour test (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>melasma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>α‐MSH expression in lesional skin (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>histopathology in Korean patients</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>membrane cofactor protein expression in vitiligo</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Merkel cell carcinoma and HIV infection (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>mesilate in treatment of hyperhidrosis (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Microsporum gypseum, subcutaneous infection (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>minoxidil in female androgenetic alopecia</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Mohs' micrographic surgery, detection of atypical melanocytes at margins of melanoma in situ</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>molluscum contagiosum</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>abnormal keratinocyte proliferation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>as presenting sign of non‐Hodgkin's lymphoma (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>morphoea profunda, TGF‐β3 expression analysis (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>MSH peptide signalling in HaCaT keratinocytes (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>mtDNA</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>histochemical and mutational analysis in tumours and matched normal human skin (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>incidence of deletion and tandem duplications in sun‐exposed human skin (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>mycosis fungoides</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>familial (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>mimicking granuloma annulare (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>naevoid hypermelanosis, linear and whorled (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>naevus, melanocytic agminated plantar (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>nails</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>brittle, as sign of recurrence of glucagonoma (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>docetaxel‐induced changes (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>involvement in pemphigus vulgaris</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>itraconazole therapy in yellow nail syndrome (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>nedocromil sodium, mechanism of inhibition of histamine‐induced itch and flare response (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Netherton syndrome, genetic analysis and prenatal testing (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>neurofibromatosis type 1 with epidermodysplasia verruciformis (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>NFAT1 expression in psoriasis and inhibition in keratinocytes by cyclosporin A (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>nickel</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>contact dermatitis due to release from the Euro (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>nickel‐exposure regulation in Denmark</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>nicotinic receptor cutaneous expression in palmoplantar pustulosis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>nitric oxide inhibitors in facial erythema and telangiectasia (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>nitric oxide synthase antagonist inhibition of UVB‐induced apoptosis of HaCaT keratinocytes (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>NOD2 gene, Crohn's syndrome‐associated insertion polymorphism (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>non‐steroidal anti‐inflammatory drugs, hypersensitivity to in Blastocystis hominis infection (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>notch4 gene and alopecia areata (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>occupational dermatitis caused by Pronematus davisi (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>oestrogen receptor expression in human dermal papilla cells (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>onychomycosis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>and Candida</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>long term results of terbinafine and itraconazole therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>terbinafine therapy in diabetes mellitus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>onychopapilloma, as clinicopathological entity (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>osteoma cutis with dysmorphic features (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>p14ARF mutational analysis in cutaneous squamous cell carcinoma (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>p16INK4a mutational analysis in cutaneous squamous cell carcinoma (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>p53 activation by UVB (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Paget's disease, extramammary, photodynamic therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>palmoplantar keratoderma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>epidermolytic, diagnosis and confirmation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hereditary focal transgressive (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>with oral leukoplakia and cutaneous horn of the lips (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>palmoplantar pustulosis, cutaneous nicotinic receptor expression</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>patch testing</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dedicated clinic (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>frequency of reactions to topical antibiotics</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>patient satisfaction</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>indicators for assessment in patients with port‐wine stains</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>with teledermatology consultations (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PCR nested assays, determination of mtDNA deletion in human skin (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pediculocide resistance in head lice</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pemphigus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>genotyping Japanese patients for HLA alleles</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>humanized SCID mouse model and autoimmunity to desmoglein‐3</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>nail involvement</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>paraneoplastic, in Castleman's disease (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>transition to pemphigus foliaceus (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pemphigus foliaceus, transition from pemphigus vulgaris (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>penciclovir dermal level measurement by cutaneous microdialysis (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>perineurioma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>sclerosing bilateral (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>subungual (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>peripheral blood basophils, diurnal variation in chronic urticaria (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>peripheral blood mononuclear cell responses to diphenylcyclopropenone (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>peroxiredoxin expression in dermatological disorders (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>persimmon leaf extracts, oral administration in mouse model of atopic dermatitis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pharmacogenetics (Review)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>photodynamic therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Bowen's disease (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cytotoxic effects on keratinocytes in vitro</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>effect on DNA base oxidation (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>effect of iron chelating agent on (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>extramammary Paget's disease</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in skin conditions other than non‐melanoma skin cancer (Review)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>topical, guidelines</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>photopatch testing results from 10‐year period in Rotterdam</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>photosensitivity, persistent, following PUVA (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>phototype (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pigmentation and UV‐induced acute erythema response (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pigmented lesions, spectrophotometric intracutaneous analysis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pilonidal sinus, cytokeratin expression</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pimecrolimus, topical, and skin atrophy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>plakophilin1, effect on keratinocytes in wound healing model (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>polyarteritis nodosa, cutaneous (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>porokeratosis of Mibelli, imiquimod therapy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>porphyria cutanea tarda, hair darkening in (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>port‐wine stains</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>indicators for assessment of quality of life and patient satisfaction</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>inheritance patterns (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>laser therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pregnancy, acanthosis nigricans (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>procyanidin B‐2, hair growth promotion</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>progressive nodular histiocytosis with hypothalamic tumour (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Pronematus davisi, epidemic occupational dermatitis caused by (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Propionobacterium acnes, T‐cell mitogenic activity and inflammation in acne</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>protectin over‐expression in non‐lesional skin in SLE (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>protoporphyrin IX, correlation between cutaneous accumulation and transdermal 5‐aminolaevulinic acid delivery</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>protothecosis, cutaneous (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in HIV infection (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pseudolymphoma induced by gold acupuncture (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pseudopelade of Brocq, clinicopathological entities within (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>psoriasis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>anti‐E‐selectin therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>chronic plaque</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>efficacy and safety of tacalcitol ointment</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PSORS1 locus characterization (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cognitive–behavioural symptom management programme as adjunct to therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>combination of lesional short‐contact dithranol therapy with potent topical corticosteroid</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>etanercept therapy (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>expression and regulation of cytoprotective genes in skin by UVR (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>generalized pustular and erythrodermic, association with bupropion treatment (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>laminin1 distribution in skin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>leflunomide therapy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>NFAT1 expression (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>non‐lesional, inflammatory response to dithranol and sodium dodecyl sulphate (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>novel immune‐based therapies (Review)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>quality of life</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>recruitment of S. pyogenes‐specific T cells to lesions (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>relapse pattern (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>TGF‐β1 polymorphisms (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>topical treatment (Review)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>psoriatic arthritis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>etanercept therapy (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>leflunomide therapy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PSORS1 gene in chronic plaque psoriasis (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PUVA</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>maintenance therapy in atopic dermatitis (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>persistent skin photosensitivity following (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pyoderma gangrenosum</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>as presentation of sarcoidosis (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>vegetative, in chronic renal failure (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>quality of life</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in atopic dermatitis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in children with atopic dermatitis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>indicators for assessment in patients with port‐wine stains</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in psoriasis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>radiation dermatitis, acute, topical corticosteroid therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>radiotherapy, lentigo maligna and lentigo maligna melanoma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Rotterdam, results from10‐year period of photopatch testing</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>S100 protein, serum levels as marker of melanoma in children (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>sarcoidosis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>during treatment of HCV infection (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>presentation with pyoderma gangrenosum (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>subcutaneous (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>scalp</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>arrector pili proximal attachment variant in terminal follicles (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>pigmented nodules (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Schistosoma mansoni, production of IL‐12 by cells in mouse skin exposed to (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>scleroderma, linear, with muscle calcification (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>sclerotherapy, effects on subclinical primary antiphospholipid syndrome (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>screening for skin cancer (Review)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>selenium</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>inhibition of UVB‐induced IL‐10 expression (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>protection of keratinocytes from chemical and UVR‐induced cell death (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>serotonin/noradrenaline reuptake inhibitor in erythromelalgia (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>severe cutaneous adverse reactions, time latency between beginning of drug use and onset of reaction (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>sexual dysfunction and thalidomide (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Singapore, prevalence and epidemiology of atopic dermatitis in school children</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>skin cancer, screening and surveillance (Review)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>skin irritation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>differences between Japanese and European women</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>proteomic analysis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>smoking, effect on collagen synthesis and extracellular matrix turnover in human skin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>sodium dodecyl sulphate, inflammatory response to in non‐lesional psoriasis (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>sodium lauryl sulphate</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>experimental itch in human skin inflamed by</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>induction of Hsp27 in human skin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>sonic hedgehog signal transducer expression by basal cell carcinoma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>spectrophotometric intracutaneous analysis of pigmented lesions</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>squamous cell carcinoma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cutaneous, mutational analysis of p16INK4a and P14ARF (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>primary cutaneous, multiprofessional management guidelines</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>role of inflammation in progression of actinic keratoses to</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>squamous syringometaplasia associated with docetaxel (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Staphylococcus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>T cell responses to (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>virulence mechanisms in human keratinocytes</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>steatocystoma multiplex, cytokeratin expression (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Still's disease, adult, serum caeruloplasmin level (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>stratum corneum, effects of rehydration on UV sensitivity</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>suction blisters, Langerhans cell human epidermal migration and TNF‐α production following formation (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>sun‐exposed human skin, mtDNA deletion and tandem duplications (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>sunscreens</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>benefits of daily use in the UK (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>and immune protection (Review)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>surveillance for skin cancer (Review)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Sweet's syndrome, lymphocytic infiltrates as presenting feature (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>systemic lupus erythematosus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>and Hermansky–Pudlak syndrome (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>induced by Epstein–Barr virus infection (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>and Kikuchi's disease (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>protectin over‐expression in non‐lesional skin (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>tacalcitol efficacy and safety in chronic plaque psoriasis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>tacrolimus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>liposomal, in immune‐mediated skin disorders</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>topical, and skin atrophy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>T cells</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>effects of cyclic oligopeptides derived by phage display (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>responses to Staphylococcus (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>sensitized, detection in drug‐allergic patients (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>S. pyogenes‐specific, recruitment to psoriasis lesions (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>telangiectasia, facial, effects of nitric oxide inhibitors (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>teledermatology consultation, patient satisfaction (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>telomerase activity correlation with telomeres in cutaneous melanocytic lesions</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>telomere evaluation in cutaneous melanocytic lesions and correlation with telomerase activity</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>terbinafine</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>long term results of therapy in onychomycosis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in refractory chromoblastomycosis (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>therapy of toenail onychomycosis in diabetes mellitus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in tinea capitis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>thalidomide and male sexual dysfunction (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>thioredoxin expression in dermatological disorders (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>thymine dimers, effects of fluoroquinolone antibiotics on formation in mouse skin (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>tinea capitis, study of oral terbinafine and high‐dose griseofulvin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>toxic epidermal necrolysis, infliximab therapy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>transforming growth factors</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>expression in morphoea profunda (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>polymorphisms in psoriasis (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>triamcinolone</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>intralesional therapy in chondrodermatitis nodularis (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in phytocosmetic cream (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>tuberculosis, cutaneous, biochemical and histochemical changes pertaining</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>tumour necrosis factor‐α, influence of ageing on Langerhans cells migration induced by</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>ultraviolet radiation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>effects of stratum corneum rehydration on sensitivity to</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>expression and regulation of cytoprotective genes in skin of psoriasis patients (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>guidelines for dosimetry and calibration in therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>UVB</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cell cycle effects and p53 activation (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>contribution of VEGF to angiogenic response</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dermal apoptosis following irradiation in eNOS knockout mouse (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>effect of acute irradiation on fibrillin‐rich microfibrils (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>induction of antinuclear and anti‐Ro/SSA antibodies in female nod mice following irradiation (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>induction of cytochrome P450 1A1 in mouse skin (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>urticaria, chronic</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>in Blastocystis hominis infection (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>diurnal variation in peripheral blood basophils (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>natural history</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>vaccination with recombinant vaccinia virus in vulval intraepithelial neoplasia (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>vascular endothelial growth factor (VEGF), contribution to angiogenic response upon UVB irradiation in vivo</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>venous leg ulcers</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>and cholesterol embolism (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>and lupus anticoagulant (Concise Communication)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>vernix caseosa, epidermal barrier lipids</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>vitamin D3 in refractory chromoblastomycosis (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>vitamin E in dapsone‐induced headache (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>vitiligo</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>melanin‐concentrating hormone receptor‐1 (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>vulval intraepithelial neoplasia, vaccination trial (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>warts</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cryotherapy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>oral zinc sulphate therapy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>regression in HIV infection following antiretroviral therapy (Clinical Cameo)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>topical immunotherapy (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>weal and flare reaction, laser‐induced</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>wet wrap dressings in atopic dermatitis (Correspondence)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>wound healing</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>effect of plakophilin 1 on keratinocytes (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>slow release iodine preparations</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>transcriptional regulation of keratinocyte activation (Abstract)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>wounds, epidermal, desmosomal adhesion regulation (Poster)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>xanthomatosis with lymphoedema, vaginal lymphorroea amd intestinal lymphangiectasia (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>yellow nail syndrome, itraconazole therapy (Case Report)</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>zinc sulphate, oral therapy in recalcitrant viral warts</value>
</json:item>
</subject>
<articleId>
<json:string>BJDBJD_V146_I6_KWDINDEX</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>index</json:string>
</originalGenre>
<qualityIndicators>
<score>3.577</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>595 x 782 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<abstractCharCount>0</abstractCharCount>
<pdfWordCount>3565</pdfWordCount>
<pdfCharCount>31168</pdfCharCount>
<pdfPageCount>9</pdfPageCount>
<abstractWordCount>1</abstractWordCount>
</qualityIndicators>
<title>Subject Index</title>
<genre>
<json:string>other</json:string>
</genre>
<host>
<title>British Journal of Dermatology</title>
<language>
<json:string>unknown</json:string>
</language>
<doi>
<json:string>10.1111/(ISSN)1365-2133</json:string>
</doi>
<issn>
<json:string>0007-0963</json:string>
</issn>
<eissn>
<json:string>1365-2133</json:string>
</eissn>
<publisherId>
<json:string>BJD</json:string>
</publisherId>
<volume>146</volume>
<issue>6</issue>
<pages>
<first>1133</first>
<last>1141</last>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
</host>
<categories>
<wos>
<json:string>science</json:string>
<json:string>dermatology</json:string>
</wos>
<scienceMetrix>
<json:string>health sciences</json:string>
<json:string>clinical medicine</json:string>
<json:string>dermatology & venereal diseases</json:string>
</scienceMetrix>
</categories>
<publicationDate>2002</publicationDate>
<copyrightDate>2002</copyrightDate>
<doi>
<json:string>10.1046/j.1365-2133.2002.t01-1-01466.x</json:string>
</doi>
<id>06575D9CFA43C3148A6BCDF7138AD5B7E364A5EF</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/06575D9CFA43C3148A6BCDF7138AD5B7E364A5EF/fulltext/pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/06575D9CFA43C3148A6BCDF7138AD5B7E364A5EF/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/06575D9CFA43C3148A6BCDF7138AD5B7E364A5EF/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main">Subject Index</title>
</titleStmt>
<publicationStmt>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-06"></date>
</publicationStmt>
<notesStmt>
<note type="content-type" subtype="other" source="index" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc>
<biblStruct type="other">
<analytic>
<title level="a" type="main">Subject Index</title>
<idno type="istex">06575D9CFA43C3148A6BCDF7138AD5B7E364A5EF</idno>
<idno type="DOI">10.1046/j.1365-2133.2002.t01-1-01466.x</idno>
<idno type="unit">BJDBJD_V146_I6_KWDINDEX</idno>
<idno type="toTypesetVersion">file:BJD.BJDBJD_V146_I6_KWDINDEX.pdf</idno>
</analytic>
<monogr>
<title level="j" type="main">British Journal of Dermatology</title>
<title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title>
<idno type="pISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<idno type="book-DOI">10.1111/(ISSN)1365-2133</idno>
<idno type="book-part-DOI">10.1111/bjd.2002.146.issue-6</idno>
<idno type="product">BJD</idno>
<idno type="publisherDivision">ST</idno>
<imprint>
<biblScope unit="vol">146</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1133">1133</biblScope>
<biblScope unit="page" to="1141">1141</biblScope>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-06"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords xml:lang="en">
<term xml:id="k1">acanthosis nigricans in pregnancy (Correspondence)</term>
<term xml:id="k2">acne</term>
<term xml:id="k3"> antimicrobial therapy (Abstract)</term>
<term xml:id="k4">
<hi rend="italic">P. acnes</hi>
T‐cell mitogenic activity and inflammation</term>
<term xml:id="k5"> prevalence of antibiotic‐resistant propionibacteria in skin</term>
<term xml:id="k6">actinic keratoses</term>
<term xml:id="k7"> role of inflammation in progression to squamous cell carcinoma</term>
<term xml:id="k8"> topical treatment with diclofenac in hyaluronan gel</term>
<term xml:id="k9">acute barrier disruption, impact of anatomical location on recovery</term>
<term xml:id="k10">acute myeloblastic leukaemia, sterile suppurative folliculitis associated (Case Report)</term>
<term xml:id="k11">adrenaline, audit of use of self‐administered syringes in angiooedema</term>
<term xml:id="k12">ageing, effects on TNFα‐induced Langerhans cell migration</term>
<term xml:id="k13">alopecia, androgenetic</term>
<term xml:id="k14">
<hi rend="italic">hairless</hi>
gene</term>
<term xml:id="k15"> minoxidil versus cyproterone acetate therapy</term>
<term xml:id="k16">alopecia areata, and
<hi rend="italic">notch4</hi>
gene (Abstract)</term>
<term xml:id="k17">α‐melanocyte‐stimulating hormone</term>
<term xml:id="k18"> expression in lesional skin of melasma (Correspondence)</term>
<term xml:id="k19"> signalling in HaCaT keratinocytes (Poster)</term>
<term xml:id="k20">5‐aminolaevulinic acid, correlation between transdermal delivery and cutaneous protoporphyrin IX accumulation</term>
<term xml:id="k21">amyloidosis, Hungarian‐type familial transthyretin (Case Report)</term>
<term xml:id="k22">anaphylaxis</term>
<term xml:id="k23"> following use of latex as hair extension adhesive (Correspondence)</term>
<term xml:id="k24"> food‐dependent exercise‐induced</term>
<term xml:id="k25">angio‐oedema</term>
<term xml:id="k26"> audit of use of self‐administered adrenaline syringes</term>
<term xml:id="k27"> natural history</term>
<term xml:id="k28"> recurrent, as presenting sign of non‐Hodgkin's B‐cell lymphoma (Correspondence)</term>
<term xml:id="k29">antibiotics, topical, frequency of patch test reactions to</term>
<term xml:id="k30">anti‐E‐selectin therapy in psoriasis</term>
<term xml:id="k31">anti‐laminin 5 pemphigoid and acquired haemophilia (Correspondence)</term>
<term xml:id="k32">antimicrobial therapy in acne (Abstract)</term>
<term xml:id="k33">antinuclear antibody induction in female nod mice following UVB irradiation (Abstract)</term>
<term xml:id="k34">antiphospholipid syndrome, subclinical, effects of sclerotherapy (Correspondence)</term>
<term xml:id="k35">antiretroviral therapy, regression of multiple warts in HIV infection following (Clinical Cameo)</term>
<term xml:id="k36">anti‐Ro/SSA antibody induction in female nod mice following UVB irradiation (Abstract)</term>
<term xml:id="k37">Apligraf
<hi rend="superscript">®</hi>
, epidermal–dermal interactions and gelatinase activity</term>
<term xml:id="k38">apoptosis, role in resolution of cutaneous antigen‐specific inflammation (Abstract)</term>
<term xml:id="k39">arrector pili proximal attachment variant in scalp terminal follicles (Concise Communication)</term>
<term xml:id="k40">arterial embolization following hyaluronic acid injection (Correspondence)</term>
<term xml:id="k41">atopic dermatitis</term>
<term xml:id="k42"> comparison of short‐use potent versus prolonged‐use mild corticosteroids (Abstract)</term>
<term xml:id="k43"> effect of primary care dermatology nurse consultation on quality of life of children</term>
<term xml:id="k44"> effects of oral persimmon leaf extracts in mouse model and hypertension</term>
<term xml:id="k45"> IL‐10 production by DER p1‐specific T cells (Abstract)</term>
<term xml:id="k46"> Langerhans cell expression of FcɛRIα receptor (Abstract)</term>
<term xml:id="k47"> maintenance PUVA therapy</term>
<term xml:id="k48"> objective method to assay itch (Abstract)</term>
<term xml:id="k49"> prevalence and epidemiology in Singapore school children</term>
<term xml:id="k50"> quality of life by body site and effect of patch testing</term>
<term xml:id="k51"> Six Area, Six Sign severity score (Concise Communication)</term>
<term xml:id="k52"> wet wrap dressings (Correspondence)</term>
<term xml:id="k53">
<hi rend="italic">ATP2A2</hi>
gene, mutation analysis in Darier's disease</term>
<term xml:id="k54">
<hi rend="italic">ATP2C1</hi>
gene, mutation analysis in Hailey–Hailey disease</term>
<term xml:id="k55">basal cell carcinoma and diet</term>
<term xml:id="k56"> expression of sonic hedgehog signal transducer</term>
<term xml:id="k57">basic fibroblast growth factor expression in familial glomangioma (Case Report)</term>
<term xml:id="k58">Behçet's disease, oral pathergy test (Correspondence)</term>
<term xml:id="k59">β‐tryptase assay and compound screening in human skin (Poster)</term>
<term xml:id="k60">Bier white spots in cryoglobulinaemia (Correspondence)</term>
<term xml:id="k61">
<hi rend="italic">Blastocystis hominis</hi>
infection, hypersensitivy to NSAIDs and chronic urticaria (Correspondence)</term>
<term xml:id="k62">Bowen's disease, photodynamic therapy (Poster)</term>
<term xml:id="k63">breast cancer</term>
<term xml:id="k64"> mimicked by subcutaneous sarcoidosis (Correspondence)</term>
<term xml:id="k65"> and persistent erythematous eyelid swelling (Clinical Cameo)</term>
<term xml:id="k66">bullous pemphigoid, extensive erosive (Correspondence)</term>
<term xml:id="k67">bupropion treatment associated with generalized pustular and erythrodermic psoriasis (Case Report)</term>
<term xml:id="k68">caeruloplasmin serum level in adult Still's disease (Case Report)</term>
<term xml:id="k69">calcipotriol</term>
<term xml:id="k70"> in erythema annulare centrifugum (Case Report)</term>
<term xml:id="k71"> in extragenital lichen sclerosus (Correspondence)</term>
<term xml:id="k72">cancer registry, electronic, in district general hospital (Poster)</term>
<term xml:id="k73">
<hi rend="italic">Candida</hi>
and onychomycosis</term>
<term xml:id="k74">carbaryl resistance in head lice</term>
<term xml:id="k75">carcinogenesis associated with human papillomaviruses, loss of gap junctional intercellular communication (Abstract)</term>
<term xml:id="k76">caspase‐1 activity regulation in human keratinocytes (Abstract)</term>
<term xml:id="k77">Castleman's disease, paraneoplastic pemphigus in (Correspondence)</term>
<term xml:id="k78">CCR7 expression in cutaneous antigen‐specific inflammation (Abstract)</term>
<term xml:id="k79">cellulitis, eosinophilic bullous (Correspondence)</term>
<term xml:id="k80">cholesterol embolism and venous leg ulcers (Correspondence)</term>
<term xml:id="k81">cholesterol embolization syndrome (Case Report)</term>
<term xml:id="k82">chondrodermatitis nodularis, intralesional triamcinolone therapy (Correspondence)</term>
<term xml:id="k83">chromoblastomycosis, vitamin D
<hi rend="subscript">3</hi>
and oral terbinafine therapy (Clinical Cameo)</term>
<term xml:id="k84">chronic renal failure with vegetative pyoderma gangrenosum (Case Report)</term>
<term xml:id="k85">citric acid treatment of non‐healing ulcers in leprosy (Clinical Cameo)</term>
<term xml:id="k86">clindamycin, cutaneous adverse reactions to</term>
<term xml:id="k87">cognitive–behavioural symptom management programme as adjunct to therapy in psoriasis</term>
<term xml:id="k88">collagenoma, isolated plantar (Correspondence)</term>
<term xml:id="k89">collagen synthesis, effects of smoking on in human skin</term>
<term xml:id="k90">connexin</term>
<term xml:id="k91"> dominant disorders (Poster)</term>
<term xml:id="k92"> 26 mutation associated with HID and KID syndromes</term>
<term xml:id="k93">contact dermatitis due to nickel release from the Euro (Correspondence)</term>
<term xml:id="k94">cornified cell envelope formation in human hair follicle development</term>
<term xml:id="k95">corticosteroids</term>
<term xml:id="k96"> comparison of short‐use potent versus prolonged‐use mild in childhood atopic dermatitis (Abstract)</term>
<term xml:id="k97"> topical</term>
<term xml:id="k98"> in acute radiation dermatitis</term>
<term xml:id="k99"> combination with lesional short‐contact dithranol therapy in psoriasis</term>
<term xml:id="k100">cryoglobulinaemia, diffuse Bier white spots in (Correspondence)</term>
<term xml:id="k101">cryotherapy, warts (Correspondence) 341 (Correspondence)</term>
<term xml:id="k102">cutaneous lupus erythematosus</term>
<term xml:id="k103"> human Ro60 (SSA2) genomic organization and sequence alterations</term>
<term xml:id="k104"> lymphocytopenia as marker of systemic involvement (Concise Communication)</term>
<term xml:id="k105">cyclic oligopeptides, effects on T cells (Abstract)</term>
<term xml:id="k106">cyclophilin dynamics (Poster)</term>
<term xml:id="k107">cyproterone acetate in female androgenetic alopecia</term>
<term xml:id="k108">cytochrome P450 1A1 induction in mouse skin by UVB (Poster)</term>
<term xml:id="k109">cytokeratin expression</term>
<term xml:id="k110"> pilonidal sinus</term>
<term xml:id="k111"> steatocystoma multiplex (Correspondence)</term>
<term xml:id="k112">Darier's disease</term>
<term xml:id="k113">
<hi rend="italic"> ATP2A2</hi>
mutation analysis</term>
<term xml:id="k114"> genetic epidemiology</term>
<term xml:id="k115"> and Kaposi's varicelliform eruption (Correspondence)</term>
<term xml:id="k116">decay accelerating factor aberrant expression in vitiligo</term>
<term xml:id="k117">Denmark, nickel‐exposure regulation</term>
<term xml:id="k118">dermal papilla cell oestrogen receptor expression (Poster)</term>
<term xml:id="k119">dermatology nurse, effect of primary care consultation on quality of life of children with atopic dermatitis</term>
<term xml:id="k120">dermatology teaching to medical students</term>
<term xml:id="k121">dermatoscope, use for early identification of melanoma using three‐colour test (Concise Communication)</term>
<term xml:id="k122">dermis</term>
<term xml:id="k123"> eNOS knockout mouse, apoptosis following UVB irradiation (Abstract)</term>
<term xml:id="k124">
<hi rend="italic">in vivo</hi>
microdialysis determination of IL‐6</term>
<term xml:id="k125">desmosome adhesion regulation in wounded epidermis (Poster)</term>
<term xml:id="k126">diabetes mellitus</term>
<term xml:id="k127"> autologous keratinocyte therapy of neuropathic foot ulcers (Poster)</term>
<term xml:id="k128"> and granuloma annulare (Concise Communication)</term>
<term xml:id="k129"> terbinafine therapy of toenail onychomycosis</term>
<term xml:id="k130">diclofenac, topical treatment of actinic keratoses</term>
<term xml:id="k131">diet and basal cell carcinoma</term>
<term xml:id="k132">diphenylcyclopropenone, responses of peripheral blood mononuclear cells to (Abstract)</term>
<term xml:id="k133">dithranol</term>
<term xml:id="k134"> combination of lesional short‐contact therapy with potent topical corticosteroid in psoriasis</term>
<term xml:id="k135"> induced tolerance in mouse ear oedema model</term>
<term xml:id="k136"> inflammation induced by, and phenotype (Poster)</term>
<term xml:id="k137"> inflammatory response to in non‐lesional psoriasis (Poster)</term>
<term xml:id="k138">docetaxel</term>
<term xml:id="k139"> association with squamous syringometaplasia (Correspondence)</term>
<term xml:id="k140"> nail changes induced by (Correspondence)</term>
<term xml:id="k141">drug allergy, blood test for confirmation (Abstract)</term>
<term xml:id="k142">dyspareunia as sign of recurrence of glucagonoma (Case Report)</term>
<term xml:id="k143">dystrophic epidermolysis bullosa, clinical spectrum</term>
<term xml:id="k144">eccrine poroma (Clinical Cameo)</term>
<term xml:id="k145">eczema
<hi rend="italic">see</hi>
atopic dermatitis</term>
<term xml:id="k146">EEC syndrome, prenatal diagnosis and
<hi rend="italic">p63</hi>
gene mutation</term>
<term xml:id="k147">elastin receptor expression in perforating skin disorders</term>
<term xml:id="k148">eNOS knockout mouse, dermal apoptosis following UVB irradiation (Abstract)</term>
<term xml:id="k149">epidermal wounds, desmosomal adhesion regulation (Poster)</term>
<term xml:id="k150">epidermodysplasia verruciformis with neurofibromatosis type 1 (Case Report)</term>
<term xml:id="k151">Epstein–Barr virus</term>
<term xml:id="k152"> in blastoid nasal T/natural killer cell lymphoma (Case Report)</term>
<term xml:id="k153"> systemic lupus erythematosus induced by infection (Case Report)</term>
<term xml:id="k154">erythema</term>
<term xml:id="k155"> facial, effects of nitric oxide inhibitors (Poster)</term>
<term xml:id="k156"> photo‐inducible mechanisms in clearance (Poster)</term>
<term xml:id="k157"> UV‐induced, and skin pigmentation (Poster)</term>
<term xml:id="k158">erythema annulare centrifugum, calcipotriol therapy (Case Report)</term>
<term xml:id="k159">erythema migrans, long‐term prognosis following treatment in France (Concise Communication)</term>
<term xml:id="k160">erythromelalgia, treatment with serotonin/noradrenaline reuptake inhibitor (Correspondence)</term>
<term xml:id="k161">etanercept</term>
<term xml:id="k162"> dermatological complications following therapy for rheumatoid arthritis (Correspondence)</term>
<term xml:id="k163"> in psoriasis and psoriatic arthritis (Concise Communication)</term>
<term xml:id="k164">Euro, nickel release and contact dermatitis (Correspondence)</term>
<term xml:id="k165">extracellular nucleotides, effect on HaCaT cells (Poster)</term>
<term xml:id="k166">extracorporeal photopheresis, induction of apoptosis in graft‐versus‐host disease and cutaneous T‐cell lymphoma</term>
<term xml:id="k167">eyelid swelling and breast cancer (Clinical Cameo)</term>
<term xml:id="k168">facial telangiectasia, effects of nitric oxide inhibitors (Poster)</term>
<term xml:id="k169">FcεRIα receptor expression by Langerhans cell in atopic dermatitis (Abstract)</term>
<term xml:id="k170">fibrillin‐rich microfibrils, effects of acute UVB irradiation on (Abstract)</term>
<term xml:id="k171">fibulin‐2 in dermis of photoaged skin (Correspondence)</term>
<term xml:id="k172">fluoroquinolone antibiotics and photosensitization of thymine dimer formation in mouse skin (Abstract)</term>
<term xml:id="k173">follicular adnexal tumours, differentiation between malignant and benign by DNA damage cytometry</term>
<term xml:id="k174">follicular hamartoma with acrochordons, seborrhoeic keratoses and chondrosarcoma (Case Report)</term>
<term xml:id="k175">folliculitis</term>
<term xml:id="k176"> with cutaneous larva migrans (Case Report)</term>
<term xml:id="k177"> sterile suppurative, associated with acute myeloblastic leukaemia (Case Report)</term>
<term xml:id="k178">foot ulcers, diabetic neuropathic, autologous keratinocyte therapy (Poster)</term>
<term xml:id="k179">free radicals in antigen formation</term>
<term xml:id="k180">glomangioma, familial, basic fibroblast growth factor expression (Case Report)</term>
<term xml:id="k181">glucagonoma, brittle nails and dyspareunia as signs of recurrence (Case Report)</term>
<term xml:id="k182">gold acupuncture, pseudolymphoma induced by (Case Report)</term>
<term xml:id="k183">graft‐versus‐host disease, induction of apoptosis by extracorporeal photopheresis</term>
<term xml:id="k184">granuloma annulare</term>
<term xml:id="k185"> and diabetes mellitus (Concise Communication)</term>
<term xml:id="k186"> treatment with a 5‐lipoxygenase inhibitor and vitamin E (Case Report)</term>
<term xml:id="k187">griseofulvin in tinea capitis</term>
<term xml:id="k188">haemangioma, hobnail, nasal dorsum (Correspondence)</term>
<term xml:id="k189">haematoma as complication of arterial Doppler studies (Correspondence)</term>
<term xml:id="k190">haemophilia, acquired, and anti‐laminin 5 pemphigoid (Correspondence)</term>
<term xml:id="k191">Hailey–Hailey disease, ATP2C1 gene mutation analysis</term>
<term xml:id="k192">hair</term>
<term xml:id="k193"> darkening in porphyria cutanea tarda (Case Report)</term>
<term xml:id="k194"> density, diameter and female pattern loss (Correspondence)</term>
<term xml:id="k195"> growth promotion with procyanidin B‐2</term>
<term xml:id="k196"> melanins and melanocortin 1 receptor status (Abstract)</term>
<term xml:id="k197">hairdressers, skin irritation thresholds</term>
<term xml:id="k198">hair follicles, formation of cornified cell envelope in development</term>
<term xml:id="k199">
<hi rend="italic">hairless</hi>
gene in androgenetic alopecia</term>
<term xml:id="k200">hand dermatitis</term>
<term xml:id="k201"> hairdressers</term>
<term xml:id="k202"> psychological factors</term>
<term xml:id="k203">headache, dapsone‐induced, vitamin E therapy (Correspondence)</term>
<term xml:id="k204">head lice resistance to pediculocides</term>
<term xml:id="k205">heart, isolated amelanotic melanoma (Case Report)</term>
<term xml:id="k206">heat shock protein</term>
<term xml:id="k207"> induction by sodium lauryl sulphate in human skin</term>
<term xml:id="k208"> upregulation in skin of patients with keratin gene mutations (Abstract)</term>
<term xml:id="k209">heat shock protein</term>
<term xml:id="k210">hepatitis C virus infection, cutaneous sarcoidosis during treatment for (Case Report)</term>
<term xml:id="k211">Hermansky–Pudlak syndrome and systemic lupus erythematosus (Case Report)</term>
<term xml:id="k212">HID syndrome and connexin 26 mutation</term>
<term xml:id="k213">histamine, pruritogenic effects in mice (Abstract)</term>
<term xml:id="k214">histiocytosis, progressive nodular, with hypothalamic tumour (Case Report)</term>
<term xml:id="k215">HIV infection</term>
<term xml:id="k216"> cutaneous protothecosis in (Correspondence)</term>
<term xml:id="k217"> and Merkel cell carcinoma (Case Report)</term>
<term xml:id="k218"> regression of multiple warts following antiretroviral therapy (Clinical Cameo)</term>
<term xml:id="k219">HLA alleles in Japanese pemphigus patients</term>
<term xml:id="k220">hobnail haemangioma of nasal dorsum (Correspondence)</term>
<term xml:id="k221">5‐HT, pruritogenic effects in mice (Abstract)</term>
<term xml:id="k222">human papillomaviruses</term>
<term xml:id="k223"> carcinogenesis associated, loss of gap junctional intercellular communication (Abstract)</term>
<term xml:id="k224"> type</term>
<term xml:id="k225">hyaluronic acid injection, arterial embolization following (Correspondence)</term>
<term xml:id="k226">hydroperoxides, reduction of contact allergic response to by epidermal antioxidant treatment</term>
<term xml:id="k227">hyperhidrosis, mesilate therapy (Correspondence)</term>
<term xml:id="k228">hypertension and atopic dermatitis</term>
<term xml:id="k229">hypothalamic tumour with progressive nodular histiocytosis (Case Report)</term>
<term xml:id="k230">imiquimod in porokeratosis of Mibelli (Correspondence)</term>
<term xml:id="k231">immune‐based therapies in psoriasis (Review)</term>
<term xml:id="k232">immunotherapy, topical, viral warts (Correspondence)</term>
<term xml:id="k233">infancy, malignant atrophic papulosis (Case Report)</term>
<term xml:id="k234">inflammation</term>
<term xml:id="k235"> cutaneous antigen‐specific, CCR7 expression and role of apoptosis in resolution (Abstract)</term>
<term xml:id="k236"> dithranol‐induced, and phenotype (Poster)</term>
<term xml:id="k237"> role in progression of actinic keratoses to squamous cell carcinoma</term>
<term xml:id="k238">infliximab in toxic epidermal necrolysis (Correspondence)</term>
<term xml:id="k239">
<hi rend="italic">ING1</hi>
overexpression in human melanoma cell lines</term>
<term xml:id="k240">interleukins</term>
<term xml:id="k241"> IL‐6,
<hi rend="italic">in vivo</hi>
microdialysis determination in human dermis</term>
<term xml:id="k242"> IL‐8, effect on HaCaT cells (Poster)</term>
<term xml:id="k243"> IL‐10</term>
<term xml:id="k244"> inhibition of UVB‐induced expression by selenium compounds (Concise Communication)</term>
<term xml:id="k245"> production by DER p1‐specific T cells in atopic dermatitis (Abstract)</term>
<term xml:id="k246"> IL‐12, production by cells in mouse skin exposed to
<hi rend="italic">S. mansoni</hi>
(Poster)</term>
<term xml:id="k247">iodine, slow release preparations and wound healing</term>
<term xml:id="k248">iron chelating agents, effects on photodynamic therapy (Abstract)</term>
<term xml:id="k249">itch</term>
<term xml:id="k250"> experimental, in sodium lauryl sulphate‐inflamed and normal human skin</term>
<term xml:id="k251"> objective method to assay in childhood atopic dermatitis (Abstract)</term>
<term xml:id="k252">itraconazole</term>
<term xml:id="k253"> long term results of therapy in onychomycosis</term>
<term xml:id="k254"> in yellow nail syndrome (Case Report)</term>
<term xml:id="k255">ITT (Correspondence)</term>
<term xml:id="k256">Kaposi's sarcoma, classic, virological status following chemotherapy/radiotherapy (Correspondence)</term>
<term xml:id="k257">Kaposi's varicelliform eruption and Darier's disease (Correspondence)</term>
<term xml:id="k258">keratin</term>
<term xml:id="k259"> characterization and regulation of type II hair‐specific genes (Abstract)</term>
<term xml:id="k260"> gene mutations and upregulation of small heat shock  protein (Hsp27) (Abstract)</term>
<term xml:id="k261">keratinocytes</term>
<term xml:id="k262"> abnormal proliferation in molluscum contagiosum</term>
<term xml:id="k263"> autologous therapy in diabetic neuropathic foot ulcers (Poster)</term>
<term xml:id="k264"> cytotoxic effects of photodynamic therapy</term>
<term xml:id="k265"> HaCaT</term>
<term xml:id="k266">  effects of IL‐8 and extracellular nucleotides on (Poster)</term>
<term xml:id="k267">  inhibition of UVB‐induced apoptosis by NO synthase  antagonists (Abstract)</term>
<term xml:id="k268">  MSH peptide signalling (Poster)</term>
<term xml:id="k269"> invasion by
<hi rend="italic">Staphylococcus aureus</hi>
</term>
<term xml:id="k270"> regulation of caspase‐1 activity (Abstract)</term>
<term xml:id="k271"> selenium‐induced protection from chemical and UVR‐induced cell death (Abstract)</term>
<term xml:id="k272"> transcriptional regulation of activation in wound healing (Abstract)</term>
<term xml:id="k273">KID syndrome and connexin mutation</term>
<term xml:id="k274">Kikuchi's disease and SLE (Correspondence)</term>
<term xml:id="k275">lactoferrin inhibition of Langerhans cell migration and TNF‐α production (Abstract)</term>
<term xml:id="k276">laminin</term>
<term xml:id="k277">Langerhans cells</term>
<term xml:id="k278"> effects of ageing on TNF‐α‐induced migration</term>
<term xml:id="k279"> expression of FcɛRIα receptor in atopic dermatitis (Abstract)</term>
<term xml:id="k280"> human epidermal migration and TNF‐α production following suction blister formation (Abstract)</term>
<term xml:id="k281"> lactoferrin inhibition of migration and TNF‐α production (Abstract)</term>
<term xml:id="k282"> regulation of migration (Poster)</term>
<term xml:id="k283">larva migrans with folliculitis (Case Report)</term>
<term xml:id="k284">laser capture microdissection of paraffin‐fixed skin sections (Poster)</term>
<term xml:id="k285">laser therapy</term>
<term xml:id="k286"> one‐pass resurfacing</term>
<term xml:id="k287"> port‐wine stains</term>
<term xml:id="k288">latex</term>
<term xml:id="k289"> contact anaphylaxis following use as hair extension adhesive (Correspondence)</term>
<term xml:id="k290"> type IV hypersensitivity reactions to</term>
<term xml:id="k291">leflunomide in severe psoriasis and psoriatic arthritis (Correspondence)</term>
<term xml:id="k292">lentigo maligna, radiotherapy</term>
<term xml:id="k293">lentigo maligna melanoma, radiotherapy</term>
<term xml:id="k294">leprosy, citric acid treatment of non‐healing ulcers (Clinical Cameo)</term>
<term xml:id="k295">leukoplakia, oral, with cutaneous horn of the lips and palmoplantar keratoderma (Case Report)</term>
<term xml:id="k296">lichen nitidus, treatment with antituberculous agent (Case Report)</term>
<term xml:id="k297">lichen sclerosus, extragenital, topical calcipotriol therapy (Correspondence)</term>
<term xml:id="k298">linear scleroderma, with muscle calcification (Case Report)</term>
<term xml:id="k299">lipomatous mixed tumour of the skin (Case Report)</term>
<term xml:id="k300">lips, cutaneous horn, with oral leukoplakia and palmoplantar keratoderma (Case Report)</term>
<term xml:id="k301">loratidine, fixed drug eruption due to (Correspondence)</term>
<term xml:id="k302">lupus anticoagulant and venous leg ulcers (Concise Communication)</term>
<term xml:id="k303">lupus erythematosus tumidus, upregulation of epidermal surface molecule expression in UVR‐induced lesions</term>
<term xml:id="k304">lupus vulgaris, diagnosis after 87 years (Correspondence)</term>
<term xml:id="k305">lymphangioendothelioma, benign (Correspondence)</term>
<term xml:id="k306">lymphocytopenia as marker of systemic involvement in cutaneous lupus erythematosus (Concise Communication)</term>
<term xml:id="k307">lymphoedema with xanthomatosis, vaginal lymphorroea amd intestinal lymphangiectasia (Case Report)</term>
<term xml:id="k308">lymphoma</term>
<term xml:id="k309"> B‐cell, presentation as recurrent angio‐oedema and molluscum contagiosum (Correspondence)</term>
<term xml:id="k310"> blastoid nasal T/natural killer cell, Epstein–Barr virus positive (Case Report)</term>
<term xml:id="k311"> cutaneous large B‐cell, similarity to chronic venous ulcer (Case Report)</term>
<term xml:id="k312"> cutaneous T‐cell</term>
<term xml:id="k313"> CD30+ with concurrent solid tumour (Case Report)</term>
<term xml:id="k314"> induction of apoptosis by extracorporeal photopheresis</term>
<term xml:id="k315"> lymphoblastoid natural killer‐cell (Case Report)</term>
<term xml:id="k316"> primary cutaneous B‐cell, absence of chromosomal translocation (Correspondence)</term>
<term xml:id="k317"> primary subcutaneous follicular centre cell, involvement of the galea (Case Report)</term>
<term xml:id="k318"> T‐zone with cutaneous involvement (Case Report)</term>
<term xml:id="k319">lymphoma molluscatum (Correspondence)</term>
<term xml:id="k320">male sexual dysfunction and thalidomide (Correspondence)</term>
<term xml:id="k321">malignant atrophic papulosis in infancy (Case Report)</term>
<term xml:id="k322">mastectomy, granulomatous lesions of homolateral limb following (Case Report)</term>
<term xml:id="k323">medical students, dermatology teaching practices</term>
<term xml:id="k324">melanin‐concentrating hormone receptor‐1 in vitiligo (Poster)</term>
<term xml:id="k325">melanins, hair, and melanocortin</term>
<term xml:id="k326">melanocortin 1 receptor</term>
<term xml:id="k327"> relationship of status to hair melanins (Abstract)</term>
<term xml:id="k328"> variants in melanoma cells (Abstract)</term>
<term xml:id="k329"> visualization (Poster)</term>
<term xml:id="k330">melanoma</term>
<term xml:id="k331"> analysis of tumour site in relation to phenotopic traits and epidemiology</term>
<term xml:id="k332"> detection of atypical marginal melanocytes using Mohs' micrographic surgery</term>
<term xml:id="k333"> detection rate, self‐examination and clinical evaluation</term>
<term xml:id="k334">
<hi rend="italic">ING1</hi>
overexpression in cell lines</term>
<term xml:id="k335"> isolated amelanotic of the heart (Case Report)</term>
<term xml:id="k336"> loss of catenin expression and disease progression (Correspondence)</term>
<term xml:id="k337"> melanocortin</term>
<term xml:id="k338"> serum S100</term>
<term xml:id="k339">  concentrations and prediction of micrometastatic disease</term>
<term xml:id="k340">  as marker in children (Correspondence)</term>
<term xml:id="k341"> tyrosinase, MIA and MART‐1 expression in sentinel lymph nodes</term>
<term xml:id="k342"> UK management guidelines</term>
<term xml:id="k343"> use of dermatoscope for early identification using three‐colour test (Concise Communication)</term>
<term xml:id="k344">melasma</term>
<term xml:id="k345"> α‐MSH expression in lesional skin (Correspondence)</term>
<term xml:id="k346"> histopathology in Korean patients</term>
<term xml:id="k347">membrane cofactor protein expression in vitiligo</term>
<term xml:id="k348">Merkel cell carcinoma and HIV infection (Case Report)</term>
<term xml:id="k349">mesilate in treatment of hyperhidrosis (Correspondence)</term>
<term xml:id="k350">
<hi rend="italic">Microsporum gypseum</hi>
, subcutaneous infection (Case Report)</term>
<term xml:id="k351">minoxidil in female androgenetic alopecia</term>
<term xml:id="k352">Mohs' micrographic surgery, detection of atypical melanocytes at margins of melanoma
<hi rend="italic">in situ</hi>
</term>
<term xml:id="k353">molluscum contagiosum</term>
<term xml:id="k354"> abnormal keratinocyte proliferation</term>
<term xml:id="k355"> as presenting sign of non‐Hodgkin's lymphoma (Correspondence)</term>
<term xml:id="k356">morphoea profunda, TGF‐β3 expression analysis (Correspondence)</term>
<term xml:id="k357">MSH peptide signalling in HaCaT keratinocytes (Poster)</term>
<term xml:id="k358">mtDNA</term>
<term xml:id="k359"> histochemical and mutational analysis in tumours and matched normal human skin (Poster)</term>
<term xml:id="k360"> incidence of deletion and tandem duplications in sun‐exposed human skin (Abstract)</term>
<term xml:id="k361">mycosis fungoides</term>
<term xml:id="k362"> familial (Correspondence)</term>
<term xml:id="k363"> mimicking granuloma annulare (Correspondence)</term>
<term xml:id="k364">naevoid hypermelanosis, linear and whorled (Case Report)</term>
<term xml:id="k365">naevus, melanocytic agminated plantar (Clinical Cameo)</term>
<term xml:id="k366">nails</term>
<term xml:id="k367"> brittle, as sign of recurrence of glucagonoma (Case Report)</term>
<term xml:id="k368"> docetaxel‐induced changes (Correspondence)</term>
<term xml:id="k369"> involvement in pemphigus vulgaris</term>
<term xml:id="k370"> itraconazole therapy in yellow nail syndrome (Case Report)</term>
<term xml:id="k371">nedocromil sodium, mechanism of inhibition of histamine‐induced itch and flare response (Abstract)</term>
<term xml:id="k372">Netherton syndrome, genetic analysis and prenatal testing (Case Report)</term>
<term xml:id="k373">neurofibromatosis type 1 with epidermodysplasia verruciformis (Case Report)</term>
<term xml:id="k374">NFAT1 expression in psoriasis and inhibition in keratinocytes by cyclosporin A (Abstract)</term>
<term xml:id="k375">nickel</term>
<term xml:id="k376"> contact dermatitis due to release from the Euro (Correspondence)</term>
<term xml:id="k377"> nickel‐exposure regulation in Denmark</term>
<term xml:id="k378">nicotinic receptor cutaneous expression in palmoplantar pustulosis</term>
<term xml:id="k379">nitric oxide inhibitors in facial erythema and telangiectasia (Poster)</term>
<term xml:id="k380">nitric oxide synthase antagonist inhibition of UVB‐induced apoptosis of HaCaT keratinocytes (Abstract)</term>
<term xml:id="k381">
<hi rend="italic">NOD2</hi>
gene, Crohn's syndrome‐associated insertion polymorphism (Poster)</term>
<term xml:id="k382">non‐steroidal anti‐inflammatory drugs, hypersensitivity to in
<hi rend="italic">Blastocystis hominis</hi>
infection (Correspondence)</term>
<term xml:id="k383">
<hi rend="italic">notch4</hi>
gene and alopecia areata (Abstract)</term>
<term xml:id="k384">occupational dermatitis caused by
<hi rend="italic">Pronematus davisi</hi>
(Correspondence)</term>
<term xml:id="k385">oestrogen receptor expression in human dermal papilla cells (Poster)</term>
<term xml:id="k386">onychomycosis</term>
<term xml:id="k387"> and
<hi rend="italic">Candida</hi>
</term>
<term xml:id="k388"> long term results of terbinafine and itraconazole therapy</term>
<term xml:id="k389"> terbinafine therapy in diabetes mellitus</term>
<term xml:id="k390">onychopapilloma, as clinicopathological entity (Correspondence)</term>
<term xml:id="k391">osteoma cutis with dysmorphic features (Case Report)</term>
<term xml:id="k392">p14
<hi rend="superscript">ARF</hi>
mutational analysis in cutaneous squamous cell carcinoma (Poster)</term>
<term xml:id="k393">p16
<hi rend="superscript">INK4a</hi>
mutational analysis in cutaneous squamous cell carcinoma (Poster)</term>
<term xml:id="k394">p53 activation by UVB (Poster)</term>
<term xml:id="k395">Paget's disease, extramammary, photodynamic therapy</term>
<term xml:id="k396">palmoplantar keratoderma</term>
<term xml:id="k397"> epidermolytic, diagnosis and confirmation</term>
<term xml:id="k398"> hereditary focal transgressive (Case Report)</term>
<term xml:id="k399"> with oral leukoplakia and cutaneous horn of the lips (Case Report)</term>
<term xml:id="k400">palmoplantar pustulosis, cutaneous nicotinic receptor expression</term>
<term xml:id="k401">patch testing</term>
<term xml:id="k402">dedicated clinic (Concise Communication)</term>
<term xml:id="k403">frequency of reactions to topical antibiotics</term>
<term xml:id="k404">patient satisfaction</term>
<term xml:id="k405"> indicators for assessment in patients with port‐wine stains</term>
<term xml:id="k406"> with teledermatology consultations (Abstract)</term>
<term xml:id="k407">PCR nested assays, determination of mtDNA deletion in human skin (Poster)</term>
<term xml:id="k408">pediculocide resistance in head lice</term>
<term xml:id="k409">pemphigus</term>
<term xml:id="k410"> genotyping Japanese patients for HLA alleles</term>
<term xml:id="k411"> humanized SCID mouse model and autoimmunity to desmoglein‐3</term>
<term xml:id="k412"> nail involvement</term>
<term xml:id="k413"> paraneoplastic, in Castleman's disease (Correspondence)</term>
<term xml:id="k414"> transition to pemphigus foliaceus (Case Report)</term>
<term xml:id="k415">pemphigus foliaceus, transition from pemphigus vulgaris (Case Report)</term>
<term xml:id="k416">penciclovir dermal level measurement by cutaneous microdialysis (Abstract)</term>
<term xml:id="k417">perineurioma</term>
<term xml:id="k418"> sclerosing bilateral (Case Report)</term>
<term xml:id="k419"> subungual (Case Report)</term>
<term xml:id="k420">peripheral blood basophils, diurnal variation in chronic urticaria (Poster)</term>
<term xml:id="k421">peripheral blood mononuclear cell responses to diphenylcyclopropenone (Abstract)</term>
<term xml:id="k422">peroxiredoxin expression in dermatological disorders (Correspondence)</term>
<term xml:id="k423">persimmon leaf extracts, oral administration in mouse model of atopic dermatitis</term>
<term xml:id="k424">pharmacogenetics (Review)</term>
<term xml:id="k425">photodynamic therapy</term>
<term xml:id="k426"> Bowen's disease (Poster)</term>
<term xml:id="k427"> cytotoxic effects on keratinocytes
<hi rend="italic">in vitro</hi>
</term>
<term xml:id="k428"> effect on DNA base oxidation (Poster)</term>
<term xml:id="k429"> effect of iron chelating agent on (Abstract)</term>
<term xml:id="k430"> extramammary Paget's disease</term>
<term xml:id="k431"> in skin conditions other than non‐melanoma skin cancer (Review)</term>
<term xml:id="k432"> topical, guidelines</term>
<term xml:id="k433">photopatch testing results from 10‐year period in Rotterdam</term>
<term xml:id="k434">photosensitivity, persistent, following PUVA (Abstract)</term>
<term xml:id="k435">phototype (Poster)</term>
<term xml:id="k436">pigmentation and UV‐induced acute erythema response (Poster)</term>
<term xml:id="k437">pigmented lesions, spectrophotometric intracutaneous analysis</term>
<term xml:id="k438">pilonidal sinus, cytokeratin expression</term>
<term xml:id="k439">pimecrolimus, topical, and skin atrophy (Correspondence)</term>
<term xml:id="k440">plakophilin1, effect on keratinocytes in wound healing model (Abstract)</term>
<term xml:id="k441">polyarteritis nodosa, cutaneous (Case Report)</term>
<term xml:id="k442">porokeratosis of Mibelli, imiquimod therapy (Correspondence)</term>
<term xml:id="k443">porphyria cutanea tarda, hair darkening in (Case Report)</term>
<term xml:id="k444">port‐wine stains</term>
<term xml:id="k445"> indicators for assessment of quality of life and patient satisfaction</term>
<term xml:id="k446"> inheritance patterns (Poster)</term>
<term xml:id="k447"> laser therapy</term>
<term xml:id="k448">pregnancy, acanthosis nigricans (Correspondence)</term>
<term xml:id="k449">procyanidin B‐2, hair growth promotion</term>
<term xml:id="k450">progressive nodular histiocytosis with hypothalamic tumour (Case Report)</term>
<term xml:id="k451">
<hi rend="italic">Pronematus davisi</hi>
, epidemic occupational dermatitis caused by (Correspondence)</term>
<term xml:id="k452">
<hi rend="italic">Propionobacterium acnes</hi>
, T‐cell mitogenic activity and inflammation in acne</term>
<term xml:id="k453">protectin over‐expression in non‐lesional skin in SLE (Abstract)</term>
<term xml:id="k454">protoporphyrin IX, correlation between cutaneous accumulation and transdermal 5‐aminolaevulinic acid delivery</term>
<term xml:id="k455">protothecosis, cutaneous (Case Report)</term>
<term xml:id="k456"> in HIV infection (Correspondence)</term>
<term xml:id="k457">pseudolymphoma induced by gold acupuncture (Case Report)</term>
<term xml:id="k458">pseudopelade of Brocq, clinicopathological entities within (Correspondence)</term>
<term xml:id="k459">psoriasis</term>
<term xml:id="k460"> anti‐E‐selectin therapy</term>
<term xml:id="k461"> chronic plaque</term>
<term xml:id="k462"> efficacy and safety of tacalcitol ointment</term>
<term xml:id="k463">
<hi rend="italic">PSORS1</hi>
locus characterization (Abstract)</term>
<term xml:id="k464"> cognitive–behavioural symptom management programme as adjunct to therapy</term>
<term xml:id="k465"> combination of lesional short‐contact dithranol therapy with potent topical corticosteroid</term>
<term xml:id="k466"> etanercept therapy (Concise Communication)</term>
<term xml:id="k467"> expression and regulation of cytoprotective genes in skin by UVR (Abstract)</term>
<term xml:id="k468"> generalized pustular and erythrodermic, association with bupropion treatment (Case Report)</term>
<term xml:id="k469"> laminin1 distribution in skin</term>
<term xml:id="k470"> leflunomide therapy (Correspondence)</term>
<term xml:id="k471"> NFAT1 expression (Abstract)</term>
<term xml:id="k472"> non‐lesional, inflammatory response to dithranol and sodium dodecyl sulphate (Poster)</term>
<term xml:id="k473"> novel immune‐based therapies (Review)</term>
<term xml:id="k474"> quality of life</term>
<term xml:id="k475"> recruitment of
<hi rend="italic">S. pyogenes</hi>
‐specific T cells to lesions (Abstract)</term>
<term xml:id="k476"> relapse pattern (Poster)</term>
<term xml:id="k477"> TGF‐β
<hi rend="subscript">1</hi>
polymorphisms (Poster)</term>
<term xml:id="k478"> topical treatment (Review)</term>
<term xml:id="k479">psoriatic arthritis</term>
<term xml:id="k480"> etanercept therapy (Concise Communication)</term>
<term xml:id="k481"> leflunomide therapy (Correspondence)</term>
<term xml:id="k482">
<hi rend="italic">PSORS1</hi>
gene in chronic plaque psoriasis (Abstract)</term>
<term xml:id="k483">PUVA</term>
<term xml:id="k484"> maintenance therapy in atopic dermatitis (Correspondence)</term>
<term xml:id="k485"> persistent skin photosensitivity following (Abstract)</term>
<term xml:id="k486">pyoderma gangrenosum</term>
<term xml:id="k487"> as presentation of sarcoidosis (Correspondence)</term>
<term xml:id="k488"> vegetative, in chronic renal failure (Case Report)</term>
<term xml:id="k489">quality of life</term>
<term xml:id="k490"> in atopic dermatitis</term>
<term xml:id="k491"> in children with atopic dermatitis</term>
<term xml:id="k492"> indicators for assessment in patients with port‐wine stains</term>
<term xml:id="k493"> in psoriasis</term>
<term xml:id="k494">radiation dermatitis, acute, topical corticosteroid therapy</term>
<term xml:id="k495">radiotherapy, lentigo maligna and lentigo maligna melanoma</term>
<term xml:id="k496">Rotterdam, results from10‐year period of photopatch testing</term>
<term xml:id="k497">S100 protein, serum levels as marker of melanoma in children (Correspondence)</term>
<term xml:id="k498">sarcoidosis</term>
<term xml:id="k499"> during treatment of HCV infection (Case Report)</term>
<term xml:id="k500"> presentation with pyoderma gangrenosum (Correspondence)</term>
<term xml:id="k501"> subcutaneous (Correspondence)</term>
<term xml:id="k502">scalp</term>
<term xml:id="k503"> arrector pili proximal attachment variant in terminal follicles (Concise Communication)</term>
<term xml:id="k504"> pigmented nodules (Clinical Cameo)</term>
<term xml:id="k505">
<hi rend="italic">Schistosoma mansoni</hi>
, production of IL‐12 by cells in mouse skin exposed to (Poster)</term>
<term xml:id="k506">scleroderma, linear, with muscle calcification (Case Report)</term>
<term xml:id="k507">sclerotherapy, effects on subclinical primary antiphospholipid syndrome (Correspondence)</term>
<term xml:id="k508">screening for skin cancer (Review)</term>
<term xml:id="k509">selenium</term>
<term xml:id="k510"> inhibition of UVB‐induced IL‐10 expression (Concise Communication)</term>
<term xml:id="k511"> protection of keratinocytes from chemical and UVR‐induced cell death (Abstract)</term>
<term xml:id="k512">serotonin/noradrenaline reuptake inhibitor in erythromelalgia (Correspondence)</term>
<term xml:id="k513">severe cutaneous adverse reactions, time latency between beginning of drug use and onset of reaction (Abstract)</term>
<term xml:id="k514">sexual dysfunction and thalidomide (Correspondence)</term>
<term xml:id="k515">Singapore, prevalence and epidemiology of atopic dermatitis in school children</term>
<term xml:id="k516">skin cancer, screening and surveillance (Review)</term>
<term xml:id="k517">skin irritation</term>
<term xml:id="k518"> differences between Japanese and European women</term>
<term xml:id="k519"> proteomic analysis</term>
<term xml:id="k520">smoking, effect on collagen synthesis and extracellular matrix turnover in human skin</term>
<term xml:id="k521">sodium dodecyl sulphate, inflammatory response to in non‐lesional psoriasis (Poster)</term>
<term xml:id="k522">sodium lauryl sulphate</term>
<term xml:id="k523"> experimental itch in human skin inflamed by</term>
<term xml:id="k524"> induction of Hsp27 in human skin</term>
<term xml:id="k525">sonic hedgehog signal transducer expression by basal cell carcinoma</term>
<term xml:id="k526">spectrophotometric intracutaneous analysis of pigmented lesions</term>
<term xml:id="k527">squamous cell carcinoma</term>
<term xml:id="k528"> cutaneous, mutational analysis of p16
<hi rend="superscript">INK4a</hi>
and P14
<hi rend="superscript">ARF</hi>
(Poster)</term>
<term xml:id="k529"> primary cutaneous, multiprofessional management guidelines</term>
<term xml:id="k530"> role of inflammation in progression of actinic keratoses to</term>
<term xml:id="k531">squamous syringometaplasia associated with docetaxel (Correspondence)</term>
<term xml:id="k532">
<hi rend="italic">Staphylococcus</hi>
</term>
<term xml:id="k533"> T cell responses to (Abstract)</term>
<term xml:id="k534"> virulence mechanisms in human keratinocytes</term>
<term xml:id="k535">steatocystoma multiplex, cytokeratin expression (Correspondence)</term>
<term xml:id="k536">Still's disease, adult, serum caeruloplasmin level (Case Report)</term>
<term xml:id="k537">stratum corneum, effects of rehydration on UV sensitivity</term>
<term xml:id="k538">suction blisters, Langerhans cell human epidermal migration and TNF‐α production following formation (Abstract)</term>
<term xml:id="k539">sun‐exposed human skin, mtDNA deletion and tandem duplications (Abstract)</term>
<term xml:id="k540">sunscreens</term>
<term xml:id="k541"> benefits of daily use in the UK (Concise Communication)</term>
<term xml:id="k542"> and immune protection (Review)</term>
<term xml:id="k543">surveillance for skin cancer (Review)</term>
<term xml:id="k544">Sweet's syndrome, lymphocytic infiltrates as presenting feature (Case Report)</term>
<term xml:id="k545">systemic lupus erythematosus</term>
<term xml:id="k546"> and Hermansky–Pudlak syndrome (Case Report)</term>
<term xml:id="k547"> induced by Epstein–Barr virus infection (Case Report)</term>
<term xml:id="k548"> and Kikuchi's disease (Correspondence)</term>
<term xml:id="k549"> protectin over‐expression in non‐lesional skin (Abstract)</term>
<term xml:id="k550">tacalcitol efficacy and safety in chronic plaque psoriasis</term>
<term xml:id="k551">tacrolimus</term>
<term xml:id="k552"> liposomal, in immune‐mediated skin disorders</term>
<term xml:id="k553"> topical, and skin atrophy (Correspondence)</term>
<term xml:id="k554">T cells</term>
<term xml:id="k555"> effects of cyclic oligopeptides derived by phage display (Abstract)</term>
<term xml:id="k556"> responses to
<hi rend="italic">Staphylococcus</hi>
(Abstract)</term>
<term xml:id="k557"> sensitized, detection in drug‐allergic patients (Abstract)</term>
<term xml:id="k558">
<hi rend="italic">S. pyogenes</hi>
‐specific, recruitment to psoriasis lesions (Abstract)</term>
<term xml:id="k559">telangiectasia, facial, effects of nitric oxide inhibitors (Poster)</term>
<term xml:id="k560">teledermatology consultation, patient satisfaction (Abstract)</term>
<term xml:id="k561">telomerase activity correlation with telomeres in cutaneous melanocytic lesions</term>
<term xml:id="k562">telomere evaluation in cutaneous melanocytic lesions and correlation with telomerase activity</term>
<term xml:id="k563">terbinafine</term>
<term xml:id="k564"> long term results of therapy in onychomycosis</term>
<term xml:id="k565"> in refractory chromoblastomycosis (Clinical Cameo)</term>
<term xml:id="k566"> therapy of toenail onychomycosis in diabetes mellitus</term>
<term xml:id="k567"> in tinea capitis</term>
<term xml:id="k568">thalidomide and male sexual dysfunction (Correspondence)</term>
<term xml:id="k569">thioredoxin expression in dermatological disorders (Correspondence)</term>
<term xml:id="k570">thymine dimers, effects of fluoroquinolone antibiotics on formation in mouse skin (Abstract)</term>
<term xml:id="k571">tinea capitis, study of oral terbinafine and high‐dose griseofulvin</term>
<term xml:id="k572">toxic epidermal necrolysis, infliximab therapy (Correspondence)</term>
<term xml:id="k573">transforming growth factors</term>
<term xml:id="k574"> expression in morphoea profunda (Correspondence)</term>
<term xml:id="k575"> polymorphisms in psoriasis (Poster)</term>
<term xml:id="k576"> triamcinolone</term>
<term xml:id="k577"> intralesional therapy in chondrodermatitis nodularis (Correspondence)</term>
<term xml:id="k578"> in phytocosmetic cream (Correspondence)</term>
<term xml:id="k579">tuberculosis, cutaneous, biochemical and histochemical changes pertaining</term>
<term xml:id="k580">tumour necrosis factor‐α, influence of ageing on Langerhans cells migration induced by</term>
<term xml:id="k581">ultraviolet radiation</term>
<term xml:id="k582"> effects of stratum corneum rehydration on sensitivity to</term>
<term xml:id="k583"> expression and regulation of cytoprotective genes in skin of psoriasis patients (Abstract)</term>
<term xml:id="k584"> guidelines for dosimetry and calibration in therapy</term>
<term xml:id="k585"> UVB</term>
<term xml:id="k586"> cell cycle effects and p53 activation (Poster)</term>
<term xml:id="k587"> contribution of VEGF to angiogenic response</term>
<term xml:id="k588"> dermal apoptosis following irradiation in eNOS knockout mouse (Abstract)</term>
<term xml:id="k589"> effect of acute irradiation on fibrillin‐rich microfibrils (Abstract)</term>
<term xml:id="k590"> induction of antinuclear and anti‐Ro/SSA antibodies in female nod mice following irradiation (Abstract)</term>
<term xml:id="k591"> induction of cytochrome P450 1A1 in mouse skin (Poster)</term>
<term xml:id="k592">urticaria, chronic</term>
<term xml:id="k593"> in
<hi rend="italic">Blastocystis hominis</hi>
infection (Correspondence)</term>
<term xml:id="k594"> diurnal variation in peripheral blood basophils (Poster)</term>
<term xml:id="k595"> natural history</term>
<term xml:id="k596">vaccination with recombinant vaccinia virus in vulval intraepithelial neoplasia (Abstract)</term>
<term xml:id="k597">vascular endothelial growth factor (VEGF), contribution to angiogenic response upon UVB irradiation
<hi rend="italic">in vivo</hi>
</term>
<term xml:id="k598">venous leg ulcers</term>
<term xml:id="k599"> and cholesterol embolism (Correspondence)</term>
<term xml:id="k600"> and lupus anticoagulant (Concise Communication)</term>
<term xml:id="k601">vernix caseosa, epidermal barrier lipids</term>
<term xml:id="k602">vitamin D
<hi rend="subscript">3</hi>
in refractory chromoblastomycosis (Clinical Cameo)</term>
<term xml:id="k603">vitamin E in dapsone‐induced headache (Correspondence)</term>
<term xml:id="k604">vitiligo</term>
<term xml:id="k605"> aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor</term>
<term xml:id="k606"> melanin‐concentrating hormone receptor‐1 (Poster)</term>
<term xml:id="k607">vulval intraepithelial neoplasia, vaccination trial (Abstract)</term>
<term xml:id="k608">warts</term>
<term xml:id="k609"> cryotherapy (Correspondence)</term>
<term xml:id="k610"> oral zinc sulphate therapy</term>
<term xml:id="k611"> regression in HIV infection following antiretroviral therapy (Clinical Cameo)</term>
<term xml:id="k612"> topical immunotherapy (Correspondence)</term>
<term xml:id="k613">weal and flare reaction, laser‐induced</term>
<term xml:id="k614">wet wrap dressings in atopic dermatitis (Correspondence)</term>
<term xml:id="k615">wound healing</term>
<term xml:id="k616"> effect of plakophilin 1 on keratinocytes (Abstract)</term>
<term xml:id="k617"> slow release iodine preparations</term>
<term xml:id="k618"> transcriptional regulation of keratinocyte activation (Abstract)</term>
<term xml:id="k619">wounds, epidermal, desmosomal adhesion regulation (Poster)</term>
<term xml:id="k620">xanthomatosis with lymphoedema, vaginal lymphorroea amd intestinal lymphangiectasia (Case Report)</term>
<term xml:id="k621">yellow nail syndrome, itraconazole therapy (Case Report)</term>
<term xml:id="k622">zinc sulphate, oral therapy in recalcitrant viral warts</term>
</keywords>
<classCode scheme="tocHeading1">Subject Index</classCode>
</textClass>
<langUsage>
<language ident="EN"></language>
</langUsage>
</profileDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/06575D9CFA43C3148A6BCDF7138AD5B7E364A5EF/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley component found">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Blackwell Science Ltd</publisherName>
<publisherLoc>Oxford, UK</publisherLoc>
</publisherInfo>
<doi origin="wiley" registered="yes">10.1111/(ISSN)1365-2133</doi>
<issn type="print">0007-0963</issn>
<issn type="electronic">1365-2133</issn>
<idGroup>
<id type="product" value="BJD"></id>
<id type="publisherDivision" value="ST"></id>
</idGroup>
<titleGroup>
<title type="main" sort="BRITISH JOURNAL OF DERMATOLOGY">British Journal of Dermatology</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="06006">
<doi origin="wiley">10.1111/bjd.2002.146.issue-6</doi>
<numberingGroup>
<numbering type="journalVolume" number="146">146</numbering>
<numbering type="journalIssue" number="6">6</numbering>
</numberingGroup>
<coverDate startDate="2002-06">June 2002</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="index" position="0113300" status="forIssue">
<doi origin="wiley">10.1046/j.1365-2133.2002.t01-1-01466.x</doi>
<idGroup>
<id type="unit" value="BJDBJD_V146_I6_KWDINDEX"></id>
</idGroup>
<titleGroup>
<title type="tocHeading1">Subject Index</title>
</titleGroup>
<eventGroup>
<event type="firstOnline" date="2002-06-19"></event>
<event type="publishedOnlineFinalForm" date="2002-06-19"></event>
<event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.6 mode:FullText source:FullText result:FullText" date="2010-04-29"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-15"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-15"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst" number="1133">1133</numbering>
<numbering type="pageLast" number="1141">1141</numbering>
</numberingGroup>
<linkGroup>
<link type="toTypesetVersion" href="file:BJD.BJDBJD_V146_I6_KWDINDEX.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<titleGroup>
<title type="main">Subject Index</title>
</titleGroup>
<keywordGroup xml:lang="en">
<keyword xml:id="k1">acanthosis nigricans in pregnancy (Correspondence)</keyword>
<keyword xml:id="k2">acne</keyword>
<keyword xml:id="k3"> antimicrobial therapy (Abstract)</keyword>
<keyword xml:id="k4">
<i>P. acnes</i>
T‐cell mitogenic activity and inflammation</keyword>
<keyword xml:id="k5"> prevalence of antibiotic‐resistant propionibacteria in skin</keyword>
<keyword xml:id="k6">actinic keratoses</keyword>
<keyword xml:id="k7"> role of inflammation in progression to squamous cell carcinoma</keyword>
<keyword xml:id="k8"> topical treatment with diclofenac in hyaluronan gel</keyword>
<keyword xml:id="k9">acute barrier disruption, impact of anatomical location on recovery</keyword>
<keyword xml:id="k10">acute myeloblastic leukaemia, sterile suppurative folliculitis associated (Case Report)</keyword>
<keyword xml:id="k11">adrenaline, audit of use of self‐administered syringes in angiooedema</keyword>
<keyword xml:id="k12">ageing, effects on TNFα‐induced Langerhans cell migration</keyword>
<keyword xml:id="k13">alopecia, androgenetic</keyword>
<keyword xml:id="k14">
<i>hairless</i>
gene</keyword>
<keyword xml:id="k15"> minoxidil versus cyproterone acetate therapy</keyword>
<keyword xml:id="k16">alopecia areata, and
<i>notch4</i>
gene (Abstract)</keyword>
<keyword xml:id="k17">α‐melanocyte‐stimulating hormone</keyword>
<keyword xml:id="k18"> expression in lesional skin of melasma (Correspondence)</keyword>
<keyword xml:id="k19"> signalling in HaCaT keratinocytes (Poster)</keyword>
<keyword xml:id="k20">5‐aminolaevulinic acid, correlation between transdermal delivery and cutaneous protoporphyrin IX accumulation</keyword>
<keyword xml:id="k21">amyloidosis, Hungarian‐type familial transthyretin (Case Report)</keyword>
<keyword xml:id="k22">anaphylaxis</keyword>
<keyword xml:id="k23"> following use of latex as hair extension adhesive (Correspondence)</keyword>
<keyword xml:id="k24"> food‐dependent exercise‐induced</keyword>
<keyword xml:id="k25">angio‐oedema</keyword>
<keyword xml:id="k26"> audit of use of self‐administered adrenaline syringes</keyword>
<keyword xml:id="k27"> natural history</keyword>
<keyword xml:id="k28"> recurrent, as presenting sign of non‐Hodgkin's B‐cell lymphoma (Correspondence)</keyword>
<keyword xml:id="k29">antibiotics, topical, frequency of patch test reactions to</keyword>
<keyword xml:id="k30">anti‐E‐selectin therapy in psoriasis</keyword>
<keyword xml:id="k31">anti‐laminin 5 pemphigoid and acquired haemophilia (Correspondence)</keyword>
<keyword xml:id="k32">antimicrobial therapy in acne (Abstract)</keyword>
<keyword xml:id="k33">antinuclear antibody induction in female nod mice following UVB irradiation (Abstract)</keyword>
<keyword xml:id="k34">antiphospholipid syndrome, subclinical, effects of sclerotherapy (Correspondence)</keyword>
<keyword xml:id="k35">antiretroviral therapy, regression of multiple warts in HIV infection following (Clinical Cameo)</keyword>
<keyword xml:id="k36">anti‐Ro/SSA antibody induction in female nod mice following UVB irradiation (Abstract)</keyword>
<keyword xml:id="k37">Apligraf
<sup>®</sup>
, epidermal–dermal interactions and gelatinase activity</keyword>
<keyword xml:id="k38">apoptosis, role in resolution of cutaneous antigen‐specific inflammation (Abstract)</keyword>
<keyword xml:id="k39">arrector pili proximal attachment variant in scalp terminal follicles (Concise Communication)</keyword>
<keyword xml:id="k40">arterial embolization following hyaluronic acid injection (Correspondence)</keyword>
<keyword xml:id="k41">atopic dermatitis</keyword>
<keyword xml:id="k42"> comparison of short‐use potent versus prolonged‐use mild corticosteroids (Abstract)</keyword>
<keyword xml:id="k43"> effect of primary care dermatology nurse consultation on quality of life of children</keyword>
<keyword xml:id="k44"> effects of oral persimmon leaf extracts in mouse model and hypertension</keyword>
<keyword xml:id="k45"> IL‐10 production by DER p1‐specific T cells (Abstract)</keyword>
<keyword xml:id="k46"> Langerhans cell expression of FcɛRIα receptor (Abstract)</keyword>
<keyword xml:id="k47"> maintenance PUVA therapy</keyword>
<keyword xml:id="k48"> objective method to assay itch (Abstract)</keyword>
<keyword xml:id="k49"> prevalence and epidemiology in Singapore school children</keyword>
<keyword xml:id="k50"> quality of life by body site and effect of patch testing</keyword>
<keyword xml:id="k51"> Six Area, Six Sign severity score (Concise Communication)</keyword>
<keyword xml:id="k52"> wet wrap dressings (Correspondence)</keyword>
<keyword xml:id="k53">
<i>ATP2A2</i>
gene, mutation analysis in Darier's disease</keyword>
<keyword xml:id="k54">
<i>ATP2C1</i>
gene, mutation analysis in Hailey–Hailey disease</keyword>
<keyword xml:id="k55">basal cell carcinoma and diet</keyword>
<keyword xml:id="k56"> expression of sonic hedgehog signal transducer</keyword>
<keyword xml:id="k57">basic fibroblast growth factor expression in familial glomangioma (Case Report)</keyword>
<keyword xml:id="k58">Behçet's disease, oral pathergy test (Correspondence)</keyword>
<keyword xml:id="k59">β‐tryptase assay and compound screening in human skin (Poster)</keyword>
<keyword xml:id="k60">Bier white spots in cryoglobulinaemia (Correspondence)</keyword>
<keyword xml:id="k61">
<i>Blastocystis hominis</i>
infection, hypersensitivy to NSAIDs and chronic urticaria (Correspondence)</keyword>
<keyword xml:id="k62">Bowen's disease, photodynamic therapy (Poster)</keyword>
<keyword xml:id="k63">breast cancer</keyword>
<keyword xml:id="k64"> mimicked by subcutaneous sarcoidosis (Correspondence)</keyword>
<keyword xml:id="k65"> and persistent erythematous eyelid swelling (Clinical Cameo)</keyword>
<keyword xml:id="k66">bullous pemphigoid, extensive erosive (Correspondence)</keyword>
<keyword xml:id="k67">bupropion treatment associated with generalized pustular and erythrodermic psoriasis (Case Report)</keyword>
<keyword xml:id="k68">caeruloplasmin serum level in adult Still's disease (Case Report)</keyword>
<keyword xml:id="k69">calcipotriol</keyword>
<keyword xml:id="k70"> in erythema annulare centrifugum (Case Report)</keyword>
<keyword xml:id="k71"> in extragenital lichen sclerosus (Correspondence)</keyword>
<keyword xml:id="k72">cancer registry, electronic, in district general hospital (Poster)</keyword>
<keyword xml:id="k73">
<i>Candida</i>
and onychomycosis</keyword>
<keyword xml:id="k74">carbaryl resistance in head lice</keyword>
<keyword xml:id="k75">carcinogenesis associated with human papillomaviruses, loss of gap junctional intercellular communication (Abstract)</keyword>
<keyword xml:id="k76">caspase‐1 activity regulation in human keratinocytes (Abstract)</keyword>
<keyword xml:id="k77">Castleman's disease, paraneoplastic pemphigus in (Correspondence)</keyword>
<keyword xml:id="k78">CCR7 expression in cutaneous antigen‐specific inflammation (Abstract)</keyword>
<keyword xml:id="k79">cellulitis, eosinophilic bullous (Correspondence)</keyword>
<keyword xml:id="k80">cholesterol embolism and venous leg ulcers (Correspondence)</keyword>
<keyword xml:id="k81">cholesterol embolization syndrome (Case Report)</keyword>
<keyword xml:id="k82">chondrodermatitis nodularis, intralesional triamcinolone therapy (Correspondence)</keyword>
<keyword xml:id="k83">chromoblastomycosis, vitamin D
<sub>3</sub>
and oral terbinafine therapy (Clinical Cameo)</keyword>
<keyword xml:id="k84">chronic renal failure with vegetative pyoderma gangrenosum (Case Report)</keyword>
<keyword xml:id="k85">citric acid treatment of non‐healing ulcers in leprosy (Clinical Cameo)</keyword>
<keyword xml:id="k86">clindamycin, cutaneous adverse reactions to</keyword>
<keyword xml:id="k87">cognitive–behavioural symptom management programme as adjunct to therapy in psoriasis</keyword>
<keyword xml:id="k88">collagenoma, isolated plantar (Correspondence)</keyword>
<keyword xml:id="k89">collagen synthesis, effects of smoking on in human skin</keyword>
<keyword xml:id="k90">connexin</keyword>
<keyword xml:id="k91"> dominant disorders (Poster)</keyword>
<keyword xml:id="k92"> 26 mutation associated with HID and KID syndromes</keyword>
<keyword xml:id="k93">contact dermatitis due to nickel release from the Euro (Correspondence)</keyword>
<keyword xml:id="k94">cornified cell envelope formation in human hair follicle development</keyword>
<keyword xml:id="k95">corticosteroids</keyword>
<keyword xml:id="k96"> comparison of short‐use potent versus prolonged‐use mild in childhood atopic dermatitis (Abstract)</keyword>
<keyword xml:id="k97"> topical</keyword>
<keyword xml:id="k98"> in acute radiation dermatitis</keyword>
<keyword xml:id="k99"> combination with lesional short‐contact dithranol therapy in psoriasis</keyword>
<keyword xml:id="k100">cryoglobulinaemia, diffuse Bier white spots in (Correspondence)</keyword>
<keyword xml:id="k101">cryotherapy, warts (Correspondence) 341 (Correspondence)</keyword>
<keyword xml:id="k102">cutaneous lupus erythematosus</keyword>
<keyword xml:id="k103"> human Ro60 (SSA2) genomic organization and sequence alterations</keyword>
<keyword xml:id="k104"> lymphocytopenia as marker of systemic involvement (Concise Communication)</keyword>
<keyword xml:id="k105">cyclic oligopeptides, effects on T cells (Abstract)</keyword>
<keyword xml:id="k106">cyclophilin dynamics (Poster)</keyword>
<keyword xml:id="k107">cyproterone acetate in female androgenetic alopecia</keyword>
<keyword xml:id="k108">cytochrome P450 1A1 induction in mouse skin by UVB (Poster)</keyword>
<keyword xml:id="k109">cytokeratin expression</keyword>
<keyword xml:id="k110"> pilonidal sinus</keyword>
<keyword xml:id="k111"> steatocystoma multiplex (Correspondence)</keyword>
<keyword xml:id="k112">Darier's disease</keyword>
<keyword xml:id="k113">
<i> ATP2A2</i>
mutation analysis</keyword>
<keyword xml:id="k114"> genetic epidemiology</keyword>
<keyword xml:id="k115"> and Kaposi's varicelliform eruption (Correspondence)</keyword>
<keyword xml:id="k116">decay accelerating factor aberrant expression in vitiligo</keyword>
<keyword xml:id="k117">Denmark, nickel‐exposure regulation</keyword>
<keyword xml:id="k118">dermal papilla cell oestrogen receptor expression (Poster)</keyword>
<keyword xml:id="k119">dermatology nurse, effect of primary care consultation on quality of life of children with atopic dermatitis</keyword>
<keyword xml:id="k120">dermatology teaching to medical students</keyword>
<keyword xml:id="k121">dermatoscope, use for early identification of melanoma using three‐colour test (Concise Communication)</keyword>
<keyword xml:id="k122">dermis</keyword>
<keyword xml:id="k123"> eNOS knockout mouse, apoptosis following UVB irradiation (Abstract)</keyword>
<keyword xml:id="k124">
<i>in vivo</i>
microdialysis determination of IL‐6</keyword>
<keyword xml:id="k125">desmosome adhesion regulation in wounded epidermis (Poster)</keyword>
<keyword xml:id="k126">diabetes mellitus</keyword>
<keyword xml:id="k127"> autologous keratinocyte therapy of neuropathic foot ulcers (Poster)</keyword>
<keyword xml:id="k128"> and granuloma annulare (Concise Communication)</keyword>
<keyword xml:id="k129"> terbinafine therapy of toenail onychomycosis</keyword>
<keyword xml:id="k130">diclofenac, topical treatment of actinic keratoses</keyword>
<keyword xml:id="k131">diet and basal cell carcinoma</keyword>
<keyword xml:id="k132">diphenylcyclopropenone, responses of peripheral blood mononuclear cells to (Abstract)</keyword>
<keyword xml:id="k133">dithranol</keyword>
<keyword xml:id="k134"> combination of lesional short‐contact therapy with potent topical corticosteroid in psoriasis</keyword>
<keyword xml:id="k135"> induced tolerance in mouse ear oedema model</keyword>
<keyword xml:id="k136"> inflammation induced by, and phenotype (Poster)</keyword>
<keyword xml:id="k137"> inflammatory response to in non‐lesional psoriasis (Poster)</keyword>
<keyword xml:id="k138">docetaxel</keyword>
<keyword xml:id="k139"> association with squamous syringometaplasia (Correspondence)</keyword>
<keyword xml:id="k140"> nail changes induced by (Correspondence)</keyword>
<keyword xml:id="k141">drug allergy, blood test for confirmation (Abstract)</keyword>
<keyword xml:id="k142">dyspareunia as sign of recurrence of glucagonoma (Case Report)</keyword>
<keyword xml:id="k143">dystrophic epidermolysis bullosa, clinical spectrum</keyword>
<keyword xml:id="k144">eccrine poroma (Clinical Cameo)</keyword>
<keyword xml:id="k145">eczema
<i>see</i>
atopic dermatitis</keyword>
<keyword xml:id="k146">EEC syndrome, prenatal diagnosis and
<i>p63</i>
gene mutation</keyword>
<keyword xml:id="k147">elastin receptor expression in perforating skin disorders</keyword>
<keyword xml:id="k148">eNOS knockout mouse, dermal apoptosis following UVB irradiation (Abstract)</keyword>
<keyword xml:id="k149">epidermal wounds, desmosomal adhesion regulation (Poster)</keyword>
<keyword xml:id="k150">epidermodysplasia verruciformis with neurofibromatosis type 1 (Case Report)</keyword>
<keyword xml:id="k151">Epstein–Barr virus</keyword>
<keyword xml:id="k152"> in blastoid nasal T/natural killer cell lymphoma (Case Report)</keyword>
<keyword xml:id="k153"> systemic lupus erythematosus induced by infection (Case Report)</keyword>
<keyword xml:id="k154">erythema</keyword>
<keyword xml:id="k155"> facial, effects of nitric oxide inhibitors (Poster)</keyword>
<keyword xml:id="k156"> photo‐inducible mechanisms in clearance (Poster)</keyword>
<keyword xml:id="k157"> UV‐induced, and skin pigmentation (Poster)</keyword>
<keyword xml:id="k158">erythema annulare centrifugum, calcipotriol therapy (Case Report)</keyword>
<keyword xml:id="k159">erythema migrans, long‐term prognosis following treatment in France (Concise Communication)</keyword>
<keyword xml:id="k160">erythromelalgia, treatment with serotonin/noradrenaline reuptake inhibitor (Correspondence)</keyword>
<keyword xml:id="k161">etanercept</keyword>
<keyword xml:id="k162"> dermatological complications following therapy for rheumatoid arthritis (Correspondence)</keyword>
<keyword xml:id="k163"> in psoriasis and psoriatic arthritis (Concise Communication)</keyword>
<keyword xml:id="k164">Euro, nickel release and contact dermatitis (Correspondence)</keyword>
<keyword xml:id="k165">extracellular nucleotides, effect on HaCaT cells (Poster)</keyword>
<keyword xml:id="k166">extracorporeal photopheresis, induction of apoptosis in graft‐versus‐host disease and cutaneous T‐cell lymphoma</keyword>
<keyword xml:id="k167">eyelid swelling and breast cancer (Clinical Cameo)</keyword>
<keyword xml:id="k168">facial telangiectasia, effects of nitric oxide inhibitors (Poster)</keyword>
<keyword xml:id="k169">FcεRIα receptor expression by Langerhans cell in atopic dermatitis (Abstract)</keyword>
<keyword xml:id="k170">fibrillin‐rich microfibrils, effects of acute UVB irradiation on (Abstract)</keyword>
<keyword xml:id="k171">fibulin‐2 in dermis of photoaged skin (Correspondence)</keyword>
<keyword xml:id="k172">fluoroquinolone antibiotics and photosensitization of thymine dimer formation in mouse skin (Abstract)</keyword>
<keyword xml:id="k173">follicular adnexal tumours, differentiation between malignant and benign by DNA damage cytometry</keyword>
<keyword xml:id="k174">follicular hamartoma with acrochordons, seborrhoeic keratoses and chondrosarcoma (Case Report)</keyword>
<keyword xml:id="k175">folliculitis</keyword>
<keyword xml:id="k176"> with cutaneous larva migrans (Case Report)</keyword>
<keyword xml:id="k177"> sterile suppurative, associated with acute myeloblastic leukaemia (Case Report)</keyword>
<keyword xml:id="k178">foot ulcers, diabetic neuropathic, autologous keratinocyte therapy (Poster)</keyword>
<keyword xml:id="k179">free radicals in antigen formation</keyword>
<keyword xml:id="k180">glomangioma, familial, basic fibroblast growth factor expression (Case Report)</keyword>
<keyword xml:id="k181">glucagonoma, brittle nails and dyspareunia as signs of recurrence (Case Report)</keyword>
<keyword xml:id="k182">gold acupuncture, pseudolymphoma induced by (Case Report)</keyword>
<keyword xml:id="k183">graft‐versus‐host disease, induction of apoptosis by extracorporeal photopheresis</keyword>
<keyword xml:id="k184">granuloma annulare</keyword>
<keyword xml:id="k185"> and diabetes mellitus (Concise Communication)</keyword>
<keyword xml:id="k186"> treatment with a 5‐lipoxygenase inhibitor and vitamin E (Case Report)</keyword>
<keyword xml:id="k187">griseofulvin in tinea capitis</keyword>
<keyword xml:id="k188">haemangioma, hobnail, nasal dorsum (Correspondence)</keyword>
<keyword xml:id="k189">haematoma as complication of arterial Doppler studies (Correspondence)</keyword>
<keyword xml:id="k190">haemophilia, acquired, and anti‐laminin 5 pemphigoid (Correspondence)</keyword>
<keyword xml:id="k191">Hailey–Hailey disease, ATP2C1 gene mutation analysis</keyword>
<keyword xml:id="k192">hair</keyword>
<keyword xml:id="k193"> darkening in porphyria cutanea tarda (Case Report)</keyword>
<keyword xml:id="k194"> density, diameter and female pattern loss (Correspondence)</keyword>
<keyword xml:id="k195"> growth promotion with procyanidin B‐2</keyword>
<keyword xml:id="k196"> melanins and melanocortin 1 receptor status (Abstract)</keyword>
<keyword xml:id="k197">hairdressers, skin irritation thresholds</keyword>
<keyword xml:id="k198">hair follicles, formation of cornified cell envelope in development</keyword>
<keyword xml:id="k199">
<i>hairless</i>
gene in androgenetic alopecia</keyword>
<keyword xml:id="k200">hand dermatitis</keyword>
<keyword xml:id="k201"> hairdressers</keyword>
<keyword xml:id="k202"> psychological factors</keyword>
<keyword xml:id="k203">headache, dapsone‐induced, vitamin E therapy (Correspondence)</keyword>
<keyword xml:id="k204">head lice resistance to pediculocides</keyword>
<keyword xml:id="k205">heart, isolated amelanotic melanoma (Case Report)</keyword>
<keyword xml:id="k206">heat shock protein</keyword>
<keyword xml:id="k207"> induction by sodium lauryl sulphate in human skin</keyword>
<keyword xml:id="k208"> upregulation in skin of patients with keratin gene mutations (Abstract)</keyword>
<keyword xml:id="k209">heat shock protein</keyword>
<keyword xml:id="k210">hepatitis C virus infection, cutaneous sarcoidosis during treatment for (Case Report)</keyword>
<keyword xml:id="k211">Hermansky–Pudlak syndrome and systemic lupus erythematosus (Case Report)</keyword>
<keyword xml:id="k212">HID syndrome and connexin 26 mutation</keyword>
<keyword xml:id="k213">histamine, pruritogenic effects in mice (Abstract)</keyword>
<keyword xml:id="k214">histiocytosis, progressive nodular, with hypothalamic tumour (Case Report)</keyword>
<keyword xml:id="k215">HIV infection</keyword>
<keyword xml:id="k216"> cutaneous protothecosis in (Correspondence)</keyword>
<keyword xml:id="k217"> and Merkel cell carcinoma (Case Report)</keyword>
<keyword xml:id="k218"> regression of multiple warts following antiretroviral therapy (Clinical Cameo)</keyword>
<keyword xml:id="k219">HLA alleles in Japanese pemphigus patients</keyword>
<keyword xml:id="k220">hobnail haemangioma of nasal dorsum (Correspondence)</keyword>
<keyword xml:id="k221">5‐HT, pruritogenic effects in mice (Abstract)</keyword>
<keyword xml:id="k222">human papillomaviruses</keyword>
<keyword xml:id="k223"> carcinogenesis associated, loss of gap junctional intercellular communication (Abstract)</keyword>
<keyword xml:id="k224"> type</keyword>
<keyword xml:id="k225">hyaluronic acid injection, arterial embolization following (Correspondence)</keyword>
<keyword xml:id="k226">hydroperoxides, reduction of contact allergic response to by epidermal antioxidant treatment</keyword>
<keyword xml:id="k227">hyperhidrosis, mesilate therapy (Correspondence)</keyword>
<keyword xml:id="k228">hypertension and atopic dermatitis</keyword>
<keyword xml:id="k229">hypothalamic tumour with progressive nodular histiocytosis (Case Report)</keyword>
<keyword xml:id="k230">imiquimod in porokeratosis of Mibelli (Correspondence)</keyword>
<keyword xml:id="k231">immune‐based therapies in psoriasis (Review)</keyword>
<keyword xml:id="k232">immunotherapy, topical, viral warts (Correspondence)</keyword>
<keyword xml:id="k233">infancy, malignant atrophic papulosis (Case Report)</keyword>
<keyword xml:id="k234">inflammation</keyword>
<keyword xml:id="k235"> cutaneous antigen‐specific, CCR7 expression and role of apoptosis in resolution (Abstract)</keyword>
<keyword xml:id="k236"> dithranol‐induced, and phenotype (Poster)</keyword>
<keyword xml:id="k237"> role in progression of actinic keratoses to squamous cell carcinoma</keyword>
<keyword xml:id="k238">infliximab in toxic epidermal necrolysis (Correspondence)</keyword>
<keyword xml:id="k239">
<i>ING1</i>
overexpression in human melanoma cell lines</keyword>
<keyword xml:id="k240">interleukins</keyword>
<keyword xml:id="k241"> IL‐6,
<i>in vivo</i>
microdialysis determination in human dermis</keyword>
<keyword xml:id="k242"> IL‐8, effect on HaCaT cells (Poster)</keyword>
<keyword xml:id="k243"> IL‐10</keyword>
<keyword xml:id="k244"> inhibition of UVB‐induced expression by selenium compounds (Concise Communication)</keyword>
<keyword xml:id="k245"> production by DER p1‐specific T cells in atopic dermatitis (Abstract)</keyword>
<keyword xml:id="k246"> IL‐12, production by cells in mouse skin exposed to
<i>S. mansoni</i>
(Poster)</keyword>
<keyword xml:id="k247">iodine, slow release preparations and wound healing</keyword>
<keyword xml:id="k248">iron chelating agents, effects on photodynamic therapy (Abstract)</keyword>
<keyword xml:id="k249">itch</keyword>
<keyword xml:id="k250"> experimental, in sodium lauryl sulphate‐inflamed and normal human skin</keyword>
<keyword xml:id="k251"> objective method to assay in childhood atopic dermatitis (Abstract)</keyword>
<keyword xml:id="k252">itraconazole</keyword>
<keyword xml:id="k253"> long term results of therapy in onychomycosis</keyword>
<keyword xml:id="k254"> in yellow nail syndrome (Case Report)</keyword>
<keyword xml:id="k255">ITT (Correspondence)</keyword>
<keyword xml:id="k256">Kaposi's sarcoma, classic, virological status following chemotherapy/radiotherapy (Correspondence)</keyword>
<keyword xml:id="k257">Kaposi's varicelliform eruption and Darier's disease (Correspondence)</keyword>
<keyword xml:id="k258">keratin</keyword>
<keyword xml:id="k259"> characterization and regulation of type II hair‐specific genes (Abstract)</keyword>
<keyword xml:id="k260"> gene mutations and upregulation of small heat shock  protein (Hsp27) (Abstract)</keyword>
<keyword xml:id="k261">keratinocytes</keyword>
<keyword xml:id="k262"> abnormal proliferation in molluscum contagiosum</keyword>
<keyword xml:id="k263"> autologous therapy in diabetic neuropathic foot ulcers (Poster)</keyword>
<keyword xml:id="k264"> cytotoxic effects of photodynamic therapy</keyword>
<keyword xml:id="k265"> HaCaT</keyword>
<keyword xml:id="k266">  effects of IL‐8 and extracellular nucleotides on (Poster)</keyword>
<keyword xml:id="k267">  inhibition of UVB‐induced apoptosis by NO synthase  antagonists (Abstract)</keyword>
<keyword xml:id="k268">  MSH peptide signalling (Poster)</keyword>
<keyword xml:id="k269"> invasion by
<i>Staphylococcus aureus</i>
</keyword>
<keyword xml:id="k270"> regulation of caspase‐1 activity (Abstract)</keyword>
<keyword xml:id="k271"> selenium‐induced protection from chemical and UVR‐induced cell death (Abstract)</keyword>
<keyword xml:id="k272"> transcriptional regulation of activation in wound healing (Abstract)</keyword>
<keyword xml:id="k273">KID syndrome and connexin mutation</keyword>
<keyword xml:id="k274">Kikuchi's disease and SLE (Correspondence)</keyword>
<keyword xml:id="k275">lactoferrin inhibition of Langerhans cell migration and TNF‐α production (Abstract)</keyword>
<keyword xml:id="k276">laminin</keyword>
<keyword xml:id="k277">Langerhans cells</keyword>
<keyword xml:id="k278"> effects of ageing on TNF‐α‐induced migration</keyword>
<keyword xml:id="k279"> expression of FcɛRIα receptor in atopic dermatitis (Abstract)</keyword>
<keyword xml:id="k280"> human epidermal migration and TNF‐α production following suction blister formation (Abstract)</keyword>
<keyword xml:id="k281"> lactoferrin inhibition of migration and TNF‐α production (Abstract)</keyword>
<keyword xml:id="k282"> regulation of migration (Poster)</keyword>
<keyword xml:id="k283">larva migrans with folliculitis (Case Report)</keyword>
<keyword xml:id="k284">laser capture microdissection of paraffin‐fixed skin sections (Poster)</keyword>
<keyword xml:id="k285">laser therapy</keyword>
<keyword xml:id="k286"> one‐pass resurfacing</keyword>
<keyword xml:id="k287"> port‐wine stains</keyword>
<keyword xml:id="k288">latex</keyword>
<keyword xml:id="k289"> contact anaphylaxis following use as hair extension adhesive (Correspondence)</keyword>
<keyword xml:id="k290"> type IV hypersensitivity reactions to</keyword>
<keyword xml:id="k291">leflunomide in severe psoriasis and psoriatic arthritis (Correspondence)</keyword>
<keyword xml:id="k292">lentigo maligna, radiotherapy</keyword>
<keyword xml:id="k293">lentigo maligna melanoma, radiotherapy</keyword>
<keyword xml:id="k294">leprosy, citric acid treatment of non‐healing ulcers (Clinical Cameo)</keyword>
<keyword xml:id="k295">leukoplakia, oral, with cutaneous horn of the lips and palmoplantar keratoderma (Case Report)</keyword>
<keyword xml:id="k296">lichen nitidus, treatment with antituberculous agent (Case Report)</keyword>
<keyword xml:id="k297">lichen sclerosus, extragenital, topical calcipotriol therapy (Correspondence)</keyword>
<keyword xml:id="k298">linear scleroderma, with muscle calcification (Case Report)</keyword>
<keyword xml:id="k299">lipomatous mixed tumour of the skin (Case Report)</keyword>
<keyword xml:id="k300">lips, cutaneous horn, with oral leukoplakia and palmoplantar keratoderma (Case Report)</keyword>
<keyword xml:id="k301">loratidine, fixed drug eruption due to (Correspondence)</keyword>
<keyword xml:id="k302">lupus anticoagulant and venous leg ulcers (Concise Communication)</keyword>
<keyword xml:id="k303">lupus erythematosus tumidus, upregulation of epidermal surface molecule expression in UVR‐induced lesions</keyword>
<keyword xml:id="k304">lupus vulgaris, diagnosis after 87 years (Correspondence)</keyword>
<keyword xml:id="k305">lymphangioendothelioma, benign (Correspondence)</keyword>
<keyword xml:id="k306">lymphocytopenia as marker of systemic involvement in cutaneous lupus erythematosus (Concise Communication)</keyword>
<keyword xml:id="k307">lymphoedema with xanthomatosis, vaginal lymphorroea amd intestinal lymphangiectasia (Case Report)</keyword>
<keyword xml:id="k308">lymphoma</keyword>
<keyword xml:id="k309"> B‐cell, presentation as recurrent angio‐oedema and molluscum contagiosum (Correspondence)</keyword>
<keyword xml:id="k310"> blastoid nasal T/natural killer cell, Epstein–Barr virus positive (Case Report)</keyword>
<keyword xml:id="k311"> cutaneous large B‐cell, similarity to chronic venous ulcer (Case Report)</keyword>
<keyword xml:id="k312"> cutaneous T‐cell</keyword>
<keyword xml:id="k313"> CD30+ with concurrent solid tumour (Case Report)</keyword>
<keyword xml:id="k314"> induction of apoptosis by extracorporeal photopheresis</keyword>
<keyword xml:id="k315"> lymphoblastoid natural killer‐cell (Case Report)</keyword>
<keyword xml:id="k316"> primary cutaneous B‐cell, absence of chromosomal translocation (Correspondence)</keyword>
<keyword xml:id="k317"> primary subcutaneous follicular centre cell, involvement of the galea (Case Report)</keyword>
<keyword xml:id="k318"> T‐zone with cutaneous involvement (Case Report)</keyword>
<keyword xml:id="k319">lymphoma molluscatum (Correspondence)</keyword>
<keyword xml:id="k320">male sexual dysfunction and thalidomide (Correspondence)</keyword>
<keyword xml:id="k321">malignant atrophic papulosis in infancy (Case Report)</keyword>
<keyword xml:id="k322">mastectomy, granulomatous lesions of homolateral limb following (Case Report)</keyword>
<keyword xml:id="k323">medical students, dermatology teaching practices</keyword>
<keyword xml:id="k324">melanin‐concentrating hormone receptor‐1 in vitiligo (Poster)</keyword>
<keyword xml:id="k325">melanins, hair, and melanocortin</keyword>
<keyword xml:id="k326">melanocortin 1 receptor</keyword>
<keyword xml:id="k327"> relationship of status to hair melanins (Abstract)</keyword>
<keyword xml:id="k328"> variants in melanoma cells (Abstract)</keyword>
<keyword xml:id="k329"> visualization (Poster)</keyword>
<keyword xml:id="k330">melanoma</keyword>
<keyword xml:id="k331"> analysis of tumour site in relation to phenotopic traits and epidemiology</keyword>
<keyword xml:id="k332"> detection of atypical marginal melanocytes using Mohs' micrographic surgery</keyword>
<keyword xml:id="k333"> detection rate, self‐examination and clinical evaluation</keyword>
<keyword xml:id="k334">
<i>ING1</i>
overexpression in cell lines</keyword>
<keyword xml:id="k335"> isolated amelanotic of the heart (Case Report)</keyword>
<keyword xml:id="k336"> loss of catenin expression and disease progression (Correspondence)</keyword>
<keyword xml:id="k337"> melanocortin</keyword>
<keyword xml:id="k338"> serum S100</keyword>
<keyword xml:id="k339">  concentrations and prediction of micrometastatic disease</keyword>
<keyword xml:id="k340">  as marker in children (Correspondence)</keyword>
<keyword xml:id="k341"> tyrosinase, MIA and MART‐1 expression in sentinel lymph nodes</keyword>
<keyword xml:id="k342"> UK management guidelines</keyword>
<keyword xml:id="k343"> use of dermatoscope for early identification using three‐colour test (Concise Communication)</keyword>
<keyword xml:id="k344">melasma</keyword>
<keyword xml:id="k345"> α‐MSH expression in lesional skin (Correspondence)</keyword>
<keyword xml:id="k346"> histopathology in Korean patients</keyword>
<keyword xml:id="k347">membrane cofactor protein expression in vitiligo</keyword>
<keyword xml:id="k348">Merkel cell carcinoma and HIV infection (Case Report)</keyword>
<keyword xml:id="k349">mesilate in treatment of hyperhidrosis (Correspondence)</keyword>
<keyword xml:id="k350">
<i>Microsporum gypseum</i>
, subcutaneous infection (Case Report)</keyword>
<keyword xml:id="k351">minoxidil in female androgenetic alopecia</keyword>
<keyword xml:id="k352">Mohs' micrographic surgery, detection of atypical melanocytes at margins of melanoma
<i>in situ</i>
</keyword>
<keyword xml:id="k353">molluscum contagiosum</keyword>
<keyword xml:id="k354"> abnormal keratinocyte proliferation</keyword>
<keyword xml:id="k355"> as presenting sign of non‐Hodgkin's lymphoma (Correspondence)</keyword>
<keyword xml:id="k356">morphoea profunda, TGF‐β3 expression analysis (Correspondence)</keyword>
<keyword xml:id="k357">MSH peptide signalling in HaCaT keratinocytes (Poster)</keyword>
<keyword xml:id="k358">mtDNA</keyword>
<keyword xml:id="k359"> histochemical and mutational analysis in tumours and matched normal human skin (Poster)</keyword>
<keyword xml:id="k360"> incidence of deletion and tandem duplications in sun‐exposed human skin (Abstract)</keyword>
<keyword xml:id="k361">mycosis fungoides</keyword>
<keyword xml:id="k362"> familial (Correspondence)</keyword>
<keyword xml:id="k363"> mimicking granuloma annulare (Correspondence)</keyword>
<keyword xml:id="k364">naevoid hypermelanosis, linear and whorled (Case Report)</keyword>
<keyword xml:id="k365">naevus, melanocytic agminated plantar (Clinical Cameo)</keyword>
<keyword xml:id="k366">nails</keyword>
<keyword xml:id="k367"> brittle, as sign of recurrence of glucagonoma (Case Report)</keyword>
<keyword xml:id="k368"> docetaxel‐induced changes (Correspondence)</keyword>
<keyword xml:id="k369"> involvement in pemphigus vulgaris</keyword>
<keyword xml:id="k370"> itraconazole therapy in yellow nail syndrome (Case Report)</keyword>
<keyword xml:id="k371">nedocromil sodium, mechanism of inhibition of histamine‐induced itch and flare response (Abstract)</keyword>
<keyword xml:id="k372">Netherton syndrome, genetic analysis and prenatal testing (Case Report)</keyword>
<keyword xml:id="k373">neurofibromatosis type 1 with epidermodysplasia verruciformis (Case Report)</keyword>
<keyword xml:id="k374">NFAT1 expression in psoriasis and inhibition in keratinocytes by cyclosporin A (Abstract)</keyword>
<keyword xml:id="k375">nickel</keyword>
<keyword xml:id="k376"> contact dermatitis due to release from the Euro (Correspondence)</keyword>
<keyword xml:id="k377"> nickel‐exposure regulation in Denmark</keyword>
<keyword xml:id="k378">nicotinic receptor cutaneous expression in palmoplantar pustulosis</keyword>
<keyword xml:id="k379">nitric oxide inhibitors in facial erythema and telangiectasia (Poster)</keyword>
<keyword xml:id="k380">nitric oxide synthase antagonist inhibition of UVB‐induced apoptosis of HaCaT keratinocytes (Abstract)</keyword>
<keyword xml:id="k381">
<i>NOD2</i>
gene, Crohn's syndrome‐associated insertion polymorphism (Poster)</keyword>
<keyword xml:id="k382">non‐steroidal anti‐inflammatory drugs, hypersensitivity to in
<i>Blastocystis hominis</i>
infection (Correspondence)</keyword>
<keyword xml:id="k383">
<i>notch4</i>
gene and alopecia areata (Abstract)</keyword>
<keyword xml:id="k384">occupational dermatitis caused by
<i>Pronematus davisi</i>
(Correspondence)</keyword>
<keyword xml:id="k385">oestrogen receptor expression in human dermal papilla cells (Poster)</keyword>
<keyword xml:id="k386">onychomycosis</keyword>
<keyword xml:id="k387"> and
<i>Candida</i>
</keyword>
<keyword xml:id="k388"> long term results of terbinafine and itraconazole therapy</keyword>
<keyword xml:id="k389"> terbinafine therapy in diabetes mellitus</keyword>
<keyword xml:id="k390">onychopapilloma, as clinicopathological entity (Correspondence)</keyword>
<keyword xml:id="k391">osteoma cutis with dysmorphic features (Case Report)</keyword>
<keyword xml:id="k392">p14
<sup>ARF</sup>
mutational analysis in cutaneous squamous cell carcinoma (Poster)</keyword>
<keyword xml:id="k393">p16
<sup>INK4a</sup>
mutational analysis in cutaneous squamous cell carcinoma (Poster)</keyword>
<keyword xml:id="k394">p53 activation by UVB (Poster)</keyword>
<keyword xml:id="k395">Paget's disease, extramammary, photodynamic therapy</keyword>
<keyword xml:id="k396">palmoplantar keratoderma</keyword>
<keyword xml:id="k397"> epidermolytic, diagnosis and confirmation</keyword>
<keyword xml:id="k398"> hereditary focal transgressive (Case Report)</keyword>
<keyword xml:id="k399"> with oral leukoplakia and cutaneous horn of the lips (Case Report)</keyword>
<keyword xml:id="k400">palmoplantar pustulosis, cutaneous nicotinic receptor expression</keyword>
<keyword xml:id="k401">patch testing</keyword>
<keyword xml:id="k402">dedicated clinic (Concise Communication)</keyword>
<keyword xml:id="k403">frequency of reactions to topical antibiotics</keyword>
<keyword xml:id="k404">patient satisfaction</keyword>
<keyword xml:id="k405"> indicators for assessment in patients with port‐wine stains</keyword>
<keyword xml:id="k406"> with teledermatology consultations (Abstract)</keyword>
<keyword xml:id="k407">PCR nested assays, determination of mtDNA deletion in human skin (Poster)</keyword>
<keyword xml:id="k408">pediculocide resistance in head lice</keyword>
<keyword xml:id="k409">pemphigus</keyword>
<keyword xml:id="k410"> genotyping Japanese patients for HLA alleles</keyword>
<keyword xml:id="k411"> humanized SCID mouse model and autoimmunity to desmoglein‐3</keyword>
<keyword xml:id="k412"> nail involvement</keyword>
<keyword xml:id="k413"> paraneoplastic, in Castleman's disease (Correspondence)</keyword>
<keyword xml:id="k414"> transition to pemphigus foliaceus (Case Report)</keyword>
<keyword xml:id="k415">pemphigus foliaceus, transition from pemphigus vulgaris (Case Report)</keyword>
<keyword xml:id="k416">penciclovir dermal level measurement by cutaneous microdialysis (Abstract)</keyword>
<keyword xml:id="k417">perineurioma</keyword>
<keyword xml:id="k418"> sclerosing bilateral (Case Report)</keyword>
<keyword xml:id="k419"> subungual (Case Report)</keyword>
<keyword xml:id="k420">peripheral blood basophils, diurnal variation in chronic urticaria (Poster)</keyword>
<keyword xml:id="k421">peripheral blood mononuclear cell responses to diphenylcyclopropenone (Abstract)</keyword>
<keyword xml:id="k422">peroxiredoxin expression in dermatological disorders (Correspondence)</keyword>
<keyword xml:id="k423">persimmon leaf extracts, oral administration in mouse model of atopic dermatitis</keyword>
<keyword xml:id="k424">pharmacogenetics (Review)</keyword>
<keyword xml:id="k425">photodynamic therapy</keyword>
<keyword xml:id="k426"> Bowen's disease (Poster)</keyword>
<keyword xml:id="k427"> cytotoxic effects on keratinocytes
<i>in vitro</i>
</keyword>
<keyword xml:id="k428"> effect on DNA base oxidation (Poster)</keyword>
<keyword xml:id="k429"> effect of iron chelating agent on (Abstract)</keyword>
<keyword xml:id="k430"> extramammary Paget's disease</keyword>
<keyword xml:id="k431"> in skin conditions other than non‐melanoma skin cancer (Review)</keyword>
<keyword xml:id="k432"> topical, guidelines</keyword>
<keyword xml:id="k433">photopatch testing results from 10‐year period in Rotterdam</keyword>
<keyword xml:id="k434">photosensitivity, persistent, following PUVA (Abstract)</keyword>
<keyword xml:id="k435">phototype (Poster)</keyword>
<keyword xml:id="k436">pigmentation and UV‐induced acute erythema response (Poster)</keyword>
<keyword xml:id="k437">pigmented lesions, spectrophotometric intracutaneous analysis</keyword>
<keyword xml:id="k438">pilonidal sinus, cytokeratin expression</keyword>
<keyword xml:id="k439">pimecrolimus, topical, and skin atrophy (Correspondence)</keyword>
<keyword xml:id="k440">plakophilin1, effect on keratinocytes in wound healing model (Abstract)</keyword>
<keyword xml:id="k441">polyarteritis nodosa, cutaneous (Case Report)</keyword>
<keyword xml:id="k442">porokeratosis of Mibelli, imiquimod therapy (Correspondence)</keyword>
<keyword xml:id="k443">porphyria cutanea tarda, hair darkening in (Case Report)</keyword>
<keyword xml:id="k444">port‐wine stains</keyword>
<keyword xml:id="k445"> indicators for assessment of quality of life and patient satisfaction</keyword>
<keyword xml:id="k446"> inheritance patterns (Poster)</keyword>
<keyword xml:id="k447"> laser therapy</keyword>
<keyword xml:id="k448">pregnancy, acanthosis nigricans (Correspondence)</keyword>
<keyword xml:id="k449">procyanidin B‐2, hair growth promotion</keyword>
<keyword xml:id="k450">progressive nodular histiocytosis with hypothalamic tumour (Case Report)</keyword>
<keyword xml:id="k451">
<i>Pronematus davisi</i>
, epidemic occupational dermatitis caused by (Correspondence)</keyword>
<keyword xml:id="k452">
<i>Propionobacterium acnes</i>
, T‐cell mitogenic activity and inflammation in acne</keyword>
<keyword xml:id="k453">protectin over‐expression in non‐lesional skin in SLE (Abstract)</keyword>
<keyword xml:id="k454">protoporphyrin IX, correlation between cutaneous accumulation and transdermal 5‐aminolaevulinic acid delivery</keyword>
<keyword xml:id="k455">protothecosis, cutaneous (Case Report)</keyword>
<keyword xml:id="k456"> in HIV infection (Correspondence)</keyword>
<keyword xml:id="k457">pseudolymphoma induced by gold acupuncture (Case Report)</keyword>
<keyword xml:id="k458">pseudopelade of Brocq, clinicopathological entities within (Correspondence)</keyword>
<keyword xml:id="k459">psoriasis</keyword>
<keyword xml:id="k460"> anti‐E‐selectin therapy</keyword>
<keyword xml:id="k461"> chronic plaque</keyword>
<keyword xml:id="k462"> efficacy and safety of tacalcitol ointment</keyword>
<keyword xml:id="k463">
<i>PSORS1</i>
locus characterization (Abstract)</keyword>
<keyword xml:id="k464"> cognitive–behavioural symptom management programme as adjunct to therapy</keyword>
<keyword xml:id="k465"> combination of lesional short‐contact dithranol therapy with potent topical corticosteroid</keyword>
<keyword xml:id="k466"> etanercept therapy (Concise Communication)</keyword>
<keyword xml:id="k467"> expression and regulation of cytoprotective genes in skin by UVR (Abstract)</keyword>
<keyword xml:id="k468"> generalized pustular and erythrodermic, association with bupropion treatment (Case Report)</keyword>
<keyword xml:id="k469"> laminin1 distribution in skin</keyword>
<keyword xml:id="k470"> leflunomide therapy (Correspondence)</keyword>
<keyword xml:id="k471"> NFAT1 expression (Abstract)</keyword>
<keyword xml:id="k472"> non‐lesional, inflammatory response to dithranol and sodium dodecyl sulphate (Poster)</keyword>
<keyword xml:id="k473"> novel immune‐based therapies (Review)</keyword>
<keyword xml:id="k474"> quality of life</keyword>
<keyword xml:id="k475"> recruitment of
<i>S. pyogenes</i>
‐specific T cells to lesions (Abstract)</keyword>
<keyword xml:id="k476"> relapse pattern (Poster)</keyword>
<keyword xml:id="k477"> TGF‐β
<sub>1</sub>
polymorphisms (Poster)</keyword>
<keyword xml:id="k478"> topical treatment (Review)</keyword>
<keyword xml:id="k479">psoriatic arthritis</keyword>
<keyword xml:id="k480"> etanercept therapy (Concise Communication)</keyword>
<keyword xml:id="k481"> leflunomide therapy (Correspondence)</keyword>
<keyword xml:id="k482">
<i>PSORS1</i>
gene in chronic plaque psoriasis (Abstract)</keyword>
<keyword xml:id="k483">PUVA</keyword>
<keyword xml:id="k484"> maintenance therapy in atopic dermatitis (Correspondence)</keyword>
<keyword xml:id="k485"> persistent skin photosensitivity following (Abstract)</keyword>
<keyword xml:id="k486">pyoderma gangrenosum</keyword>
<keyword xml:id="k487"> as presentation of sarcoidosis (Correspondence)</keyword>
<keyword xml:id="k488"> vegetative, in chronic renal failure (Case Report)</keyword>
<keyword xml:id="k489">quality of life</keyword>
<keyword xml:id="k490"> in atopic dermatitis</keyword>
<keyword xml:id="k491"> in children with atopic dermatitis</keyword>
<keyword xml:id="k492"> indicators for assessment in patients with port‐wine stains</keyword>
<keyword xml:id="k493"> in psoriasis</keyword>
<keyword xml:id="k494">radiation dermatitis, acute, topical corticosteroid therapy</keyword>
<keyword xml:id="k495">radiotherapy, lentigo maligna and lentigo maligna melanoma</keyword>
<keyword xml:id="k496">Rotterdam, results from10‐year period of photopatch testing</keyword>
<keyword xml:id="k497">S100 protein, serum levels as marker of melanoma in children (Correspondence)</keyword>
<keyword xml:id="k498">sarcoidosis</keyword>
<keyword xml:id="k499"> during treatment of HCV infection (Case Report)</keyword>
<keyword xml:id="k500"> presentation with pyoderma gangrenosum (Correspondence)</keyword>
<keyword xml:id="k501"> subcutaneous (Correspondence)</keyword>
<keyword xml:id="k502">scalp</keyword>
<keyword xml:id="k503"> arrector pili proximal attachment variant in terminal follicles (Concise Communication)</keyword>
<keyword xml:id="k504"> pigmented nodules (Clinical Cameo)</keyword>
<keyword xml:id="k505">
<i>Schistosoma mansoni</i>
, production of IL‐12 by cells in mouse skin exposed to (Poster)</keyword>
<keyword xml:id="k506">scleroderma, linear, with muscle calcification (Case Report)</keyword>
<keyword xml:id="k507">sclerotherapy, effects on subclinical primary antiphospholipid syndrome (Correspondence)</keyword>
<keyword xml:id="k508">screening for skin cancer (Review)</keyword>
<keyword xml:id="k509">selenium</keyword>
<keyword xml:id="k510"> inhibition of UVB‐induced IL‐10 expression (Concise Communication)</keyword>
<keyword xml:id="k511"> protection of keratinocytes from chemical and UVR‐induced cell death (Abstract)</keyword>
<keyword xml:id="k512">serotonin/noradrenaline reuptake inhibitor in erythromelalgia (Correspondence)</keyword>
<keyword xml:id="k513">severe cutaneous adverse reactions, time latency between beginning of drug use and onset of reaction (Abstract)</keyword>
<keyword xml:id="k514">sexual dysfunction and thalidomide (Correspondence)</keyword>
<keyword xml:id="k515">Singapore, prevalence and epidemiology of atopic dermatitis in school children</keyword>
<keyword xml:id="k516">skin cancer, screening and surveillance (Review)</keyword>
<keyword xml:id="k517">skin irritation</keyword>
<keyword xml:id="k518"> differences between Japanese and European women</keyword>
<keyword xml:id="k519"> proteomic analysis</keyword>
<keyword xml:id="k520">smoking, effect on collagen synthesis and extracellular matrix turnover in human skin</keyword>
<keyword xml:id="k521">sodium dodecyl sulphate, inflammatory response to in non‐lesional psoriasis (Poster)</keyword>
<keyword xml:id="k522">sodium lauryl sulphate</keyword>
<keyword xml:id="k523"> experimental itch in human skin inflamed by</keyword>
<keyword xml:id="k524"> induction of Hsp27 in human skin</keyword>
<keyword xml:id="k525">sonic hedgehog signal transducer expression by basal cell carcinoma</keyword>
<keyword xml:id="k526">spectrophotometric intracutaneous analysis of pigmented lesions</keyword>
<keyword xml:id="k527">squamous cell carcinoma</keyword>
<keyword xml:id="k528"> cutaneous, mutational analysis of p16
<sup>INK4a</sup>
and P14
<sup>ARF</sup>
(Poster)</keyword>
<keyword xml:id="k529"> primary cutaneous, multiprofessional management guidelines</keyword>
<keyword xml:id="k530"> role of inflammation in progression of actinic keratoses to</keyword>
<keyword xml:id="k531">squamous syringometaplasia associated with docetaxel (Correspondence)</keyword>
<keyword xml:id="k532">
<i>Staphylococcus</i>
</keyword>
<keyword xml:id="k533"> T cell responses to (Abstract)</keyword>
<keyword xml:id="k534"> virulence mechanisms in human keratinocytes</keyword>
<keyword xml:id="k535">steatocystoma multiplex, cytokeratin expression (Correspondence)</keyword>
<keyword xml:id="k536">Still's disease, adult, serum caeruloplasmin level (Case Report)</keyword>
<keyword xml:id="k537">stratum corneum, effects of rehydration on UV sensitivity</keyword>
<keyword xml:id="k538">suction blisters, Langerhans cell human epidermal migration and TNF‐α production following formation (Abstract)</keyword>
<keyword xml:id="k539">sun‐exposed human skin, mtDNA deletion and tandem duplications (Abstract)</keyword>
<keyword xml:id="k540">sunscreens</keyword>
<keyword xml:id="k541"> benefits of daily use in the UK (Concise Communication)</keyword>
<keyword xml:id="k542"> and immune protection (Review)</keyword>
<keyword xml:id="k543">surveillance for skin cancer (Review)</keyword>
<keyword xml:id="k544">Sweet's syndrome, lymphocytic infiltrates as presenting feature (Case Report)</keyword>
<keyword xml:id="k545">systemic lupus erythematosus</keyword>
<keyword xml:id="k546"> and Hermansky–Pudlak syndrome (Case Report)</keyword>
<keyword xml:id="k547"> induced by Epstein–Barr virus infection (Case Report)</keyword>
<keyword xml:id="k548"> and Kikuchi's disease (Correspondence)</keyword>
<keyword xml:id="k549"> protectin over‐expression in non‐lesional skin (Abstract)</keyword>
<keyword xml:id="k550">tacalcitol efficacy and safety in chronic plaque psoriasis</keyword>
<keyword xml:id="k551">tacrolimus</keyword>
<keyword xml:id="k552"> liposomal, in immune‐mediated skin disorders</keyword>
<keyword xml:id="k553"> topical, and skin atrophy (Correspondence)</keyword>
<keyword xml:id="k554">T cells</keyword>
<keyword xml:id="k555"> effects of cyclic oligopeptides derived by phage display (Abstract)</keyword>
<keyword xml:id="k556"> responses to
<i>Staphylococcus</i>
(Abstract)</keyword>
<keyword xml:id="k557"> sensitized, detection in drug‐allergic patients (Abstract)</keyword>
<keyword xml:id="k558">
<i>S. pyogenes</i>
‐specific, recruitment to psoriasis lesions (Abstract)</keyword>
<keyword xml:id="k559">telangiectasia, facial, effects of nitric oxide inhibitors (Poster)</keyword>
<keyword xml:id="k560">teledermatology consultation, patient satisfaction (Abstract)</keyword>
<keyword xml:id="k561">telomerase activity correlation with telomeres in cutaneous melanocytic lesions</keyword>
<keyword xml:id="k562">telomere evaluation in cutaneous melanocytic lesions and correlation with telomerase activity</keyword>
<keyword xml:id="k563">terbinafine</keyword>
<keyword xml:id="k564"> long term results of therapy in onychomycosis</keyword>
<keyword xml:id="k565"> in refractory chromoblastomycosis (Clinical Cameo)</keyword>
<keyword xml:id="k566"> therapy of toenail onychomycosis in diabetes mellitus</keyword>
<keyword xml:id="k567"> in tinea capitis</keyword>
<keyword xml:id="k568">thalidomide and male sexual dysfunction (Correspondence)</keyword>
<keyword xml:id="k569">thioredoxin expression in dermatological disorders (Correspondence)</keyword>
<keyword xml:id="k570">thymine dimers, effects of fluoroquinolone antibiotics on formation in mouse skin (Abstract)</keyword>
<keyword xml:id="k571">tinea capitis, study of oral terbinafine and high‐dose griseofulvin</keyword>
<keyword xml:id="k572">toxic epidermal necrolysis, infliximab therapy (Correspondence)</keyword>
<keyword xml:id="k573">transforming growth factors</keyword>
<keyword xml:id="k574"> expression in morphoea profunda (Correspondence)</keyword>
<keyword xml:id="k575"> polymorphisms in psoriasis (Poster)</keyword>
<keyword xml:id="k576"> triamcinolone</keyword>
<keyword xml:id="k577"> intralesional therapy in chondrodermatitis nodularis (Correspondence)</keyword>
<keyword xml:id="k578"> in phytocosmetic cream (Correspondence)</keyword>
<keyword xml:id="k579">tuberculosis, cutaneous, biochemical and histochemical changes pertaining</keyword>
<keyword xml:id="k580">tumour necrosis factor‐α, influence of ageing on Langerhans cells migration induced by</keyword>
<keyword xml:id="k581">ultraviolet radiation</keyword>
<keyword xml:id="k582"> effects of stratum corneum rehydration on sensitivity to</keyword>
<keyword xml:id="k583"> expression and regulation of cytoprotective genes in skin of psoriasis patients (Abstract)</keyword>
<keyword xml:id="k584"> guidelines for dosimetry and calibration in therapy</keyword>
<keyword xml:id="k585"> UVB</keyword>
<keyword xml:id="k586"> cell cycle effects and p53 activation (Poster)</keyword>
<keyword xml:id="k587"> contribution of VEGF to angiogenic response</keyword>
<keyword xml:id="k588"> dermal apoptosis following irradiation in eNOS knockout mouse (Abstract)</keyword>
<keyword xml:id="k589"> effect of acute irradiation on fibrillin‐rich microfibrils (Abstract)</keyword>
<keyword xml:id="k590"> induction of antinuclear and anti‐Ro/SSA antibodies in female nod mice following irradiation (Abstract)</keyword>
<keyword xml:id="k591"> induction of cytochrome P450 1A1 in mouse skin (Poster)</keyword>
<keyword xml:id="k592">urticaria, chronic</keyword>
<keyword xml:id="k593"> in
<i>Blastocystis hominis</i>
infection (Correspondence)</keyword>
<keyword xml:id="k594"> diurnal variation in peripheral blood basophils (Poster)</keyword>
<keyword xml:id="k595"> natural history</keyword>
<keyword xml:id="k596">vaccination with recombinant vaccinia virus in vulval intraepithelial neoplasia (Abstract)</keyword>
<keyword xml:id="k597">vascular endothelial growth factor (VEGF), contribution to angiogenic response upon UVB irradiation
<i>in vivo</i>
</keyword>
<keyword xml:id="k598">venous leg ulcers</keyword>
<keyword xml:id="k599"> and cholesterol embolism (Correspondence)</keyword>
<keyword xml:id="k600"> and lupus anticoagulant (Concise Communication)</keyword>
<keyword xml:id="k601">vernix caseosa, epidermal barrier lipids</keyword>
<keyword xml:id="k602">vitamin D
<sub>3</sub>
in refractory chromoblastomycosis (Clinical Cameo)</keyword>
<keyword xml:id="k603">vitamin E in dapsone‐induced headache (Correspondence)</keyword>
<keyword xml:id="k604">vitiligo</keyword>
<keyword xml:id="k605"> aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor</keyword>
<keyword xml:id="k606"> melanin‐concentrating hormone receptor‐1 (Poster)</keyword>
<keyword xml:id="k607">vulval intraepithelial neoplasia, vaccination trial (Abstract)</keyword>
<keyword xml:id="k608">warts</keyword>
<keyword xml:id="k609"> cryotherapy (Correspondence)</keyword>
<keyword xml:id="k610"> oral zinc sulphate therapy</keyword>
<keyword xml:id="k611"> regression in HIV infection following antiretroviral therapy (Clinical Cameo)</keyword>
<keyword xml:id="k612"> topical immunotherapy (Correspondence)</keyword>
<keyword xml:id="k613">weal and flare reaction, laser‐induced</keyword>
<keyword xml:id="k614">wet wrap dressings in atopic dermatitis (Correspondence)</keyword>
<keyword xml:id="k615">wound healing</keyword>
<keyword xml:id="k616"> effect of plakophilin 1 on keratinocytes (Abstract)</keyword>
<keyword xml:id="k617"> slow release iodine preparations</keyword>
<keyword xml:id="k618"> transcriptional regulation of keratinocyte activation (Abstract)</keyword>
<keyword xml:id="k619">wounds, epidermal, desmosomal adhesion regulation (Poster)</keyword>
<keyword xml:id="k620">xanthomatosis with lymphoedema, vaginal lymphorroea amd intestinal lymphangiectasia (Case Report)</keyword>
<keyword xml:id="k621">yellow nail syndrome, itraconazole therapy (Case Report)</keyword>
<keyword xml:id="k622">zinc sulphate, oral therapy in recalcitrant viral warts</keyword>
</keywordGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Subject Index</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Subject Index</title>
</titleInfo>
<typeOfResource>text</typeOfResource>
<genre type="other" displayLabel="index"></genre>
<originInfo>
<publisher>Blackwell Science Ltd</publisher>
<place>
<placeTerm type="text">Oxford, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2002-06</dateIssued>
<copyrightDate encoding="w3cdtf">2002</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<subject lang="en">
<genre>keywords</genre>
<topic>acanthosis nigricans in pregnancy (Correspondence)</topic>
<topic>acne</topic>
<topic> antimicrobial therapy (Abstract)</topic>
<topic> P. acnes T‐cell mitogenic activity and inflammation</topic>
<topic> prevalence of antibiotic‐resistant propionibacteria in skin</topic>
<topic>actinic keratoses</topic>
<topic> role of inflammation in progression to squamous cell carcinoma</topic>
<topic> topical treatment with diclofenac in hyaluronan gel</topic>
<topic>acute barrier disruption, impact of anatomical location on recovery</topic>
<topic>acute myeloblastic leukaemia, sterile suppurative folliculitis associated (Case Report)</topic>
<topic>adrenaline, audit of use of self‐administered syringes in angiooedema</topic>
<topic>ageing, effects on TNFα‐induced Langerhans cell migration</topic>
<topic>alopecia, androgenetic</topic>
<topic> hairless gene</topic>
<topic> minoxidil versus cyproterone acetate therapy</topic>
<topic>alopecia areata, and notch4 gene (Abstract)</topic>
<topic>α‐melanocyte‐stimulating hormone</topic>
<topic> expression in lesional skin of melasma (Correspondence)</topic>
<topic> signalling in HaCaT keratinocytes (Poster)</topic>
<topic>5‐aminolaevulinic acid, correlation between transdermal delivery and cutaneous protoporphyrin IX accumulation</topic>
<topic>amyloidosis, Hungarian‐type familial transthyretin (Case Report)</topic>
<topic>anaphylaxis</topic>
<topic> following use of latex as hair extension adhesive (Correspondence)</topic>
<topic> food‐dependent exercise‐induced</topic>
<topic>angio‐oedema</topic>
<topic> audit of use of self‐administered adrenaline syringes</topic>
<topic> natural history</topic>
<topic> recurrent, as presenting sign of non‐Hodgkin's B‐cell lymphoma (Correspondence)</topic>
<topic>antibiotics, topical, frequency of patch test reactions to</topic>
<topic>anti‐E‐selectin therapy in psoriasis</topic>
<topic>anti‐laminin 5 pemphigoid and acquired haemophilia (Correspondence)</topic>
<topic>antimicrobial therapy in acne (Abstract)</topic>
<topic>antinuclear antibody induction in female nod mice following UVB irradiation (Abstract)</topic>
<topic>antiphospholipid syndrome, subclinical, effects of sclerotherapy (Correspondence)</topic>
<topic>antiretroviral therapy, regression of multiple warts in HIV infection following (Clinical Cameo)</topic>
<topic>anti‐Ro/SSA antibody induction in female nod mice following UVB irradiation (Abstract)</topic>
<topic>Apligraf®, epidermal–dermal interactions and gelatinase activity</topic>
<topic>apoptosis, role in resolution of cutaneous antigen‐specific inflammation (Abstract)</topic>
<topic>arrector pili proximal attachment variant in scalp terminal follicles (Concise Communication)</topic>
<topic>arterial embolization following hyaluronic acid injection (Correspondence)</topic>
<topic>atopic dermatitis</topic>
<topic> comparison of short‐use potent versus prolonged‐use mild corticosteroids (Abstract)</topic>
<topic> effect of primary care dermatology nurse consultation on quality of life of children</topic>
<topic> effects of oral persimmon leaf extracts in mouse model and hypertension</topic>
<topic> IL‐10 production by DER p1‐specific T cells (Abstract)</topic>
<topic> Langerhans cell expression of FcɛRIα receptor (Abstract)</topic>
<topic> maintenance PUVA therapy</topic>
<topic> objective method to assay itch (Abstract)</topic>
<topic> prevalence and epidemiology in Singapore school children</topic>
<topic> quality of life by body site and effect of patch testing</topic>
<topic> Six Area, Six Sign severity score (Concise Communication)</topic>
<topic> wet wrap dressings (Correspondence)</topic>
<topic>ATP2A2 gene, mutation analysis in Darier's disease</topic>
<topic>ATP2C1 gene, mutation analysis in Hailey–Hailey disease</topic>
<topic>basal cell carcinoma and diet</topic>
<topic> expression of sonic hedgehog signal transducer</topic>
<topic>basic fibroblast growth factor expression in familial glomangioma (Case Report)</topic>
<topic>Behçet's disease, oral pathergy test (Correspondence)</topic>
<topic>β‐tryptase assay and compound screening in human skin (Poster)</topic>
<topic>Bier white spots in cryoglobulinaemia (Correspondence)</topic>
<topic>Blastocystis hominis infection, hypersensitivy to NSAIDs and chronic urticaria (Correspondence)</topic>
<topic>Bowen's disease, photodynamic therapy (Poster)</topic>
<topic>breast cancer</topic>
<topic> mimicked by subcutaneous sarcoidosis (Correspondence)</topic>
<topic> and persistent erythematous eyelid swelling (Clinical Cameo)</topic>
<topic>bullous pemphigoid, extensive erosive (Correspondence)</topic>
<topic>bupropion treatment associated with generalized pustular and erythrodermic psoriasis (Case Report)</topic>
<topic>caeruloplasmin serum level in adult Still's disease (Case Report)</topic>
<topic>calcipotriol</topic>
<topic> in erythema annulare centrifugum (Case Report)</topic>
<topic> in extragenital lichen sclerosus (Correspondence)</topic>
<topic>cancer registry, electronic, in district general hospital (Poster)</topic>
<topic>Candida and onychomycosis</topic>
<topic>carbaryl resistance in head lice</topic>
<topic>carcinogenesis associated with human papillomaviruses, loss of gap junctional intercellular communication (Abstract)</topic>
<topic>caspase‐1 activity regulation in human keratinocytes (Abstract)</topic>
<topic>Castleman's disease, paraneoplastic pemphigus in (Correspondence)</topic>
<topic>CCR7 expression in cutaneous antigen‐specific inflammation (Abstract)</topic>
<topic>cellulitis, eosinophilic bullous (Correspondence)</topic>
<topic>cholesterol embolism and venous leg ulcers (Correspondence)</topic>
<topic>cholesterol embolization syndrome (Case Report)</topic>
<topic>chondrodermatitis nodularis, intralesional triamcinolone therapy (Correspondence)</topic>
<topic>chromoblastomycosis, vitamin D3 and oral terbinafine therapy (Clinical Cameo)</topic>
<topic>chronic renal failure with vegetative pyoderma gangrenosum (Case Report)</topic>
<topic>citric acid treatment of non‐healing ulcers in leprosy (Clinical Cameo)</topic>
<topic>clindamycin, cutaneous adverse reactions to</topic>
<topic>cognitive–behavioural symptom management programme as adjunct to therapy in psoriasis</topic>
<topic>collagenoma, isolated plantar (Correspondence)</topic>
<topic>collagen synthesis, effects of smoking on in human skin</topic>
<topic>connexin</topic>
<topic> dominant disorders (Poster)</topic>
<topic> 26 mutation associated with HID and KID syndromes</topic>
<topic>contact dermatitis due to nickel release from the Euro (Correspondence)</topic>
<topic>cornified cell envelope formation in human hair follicle development</topic>
<topic>corticosteroids</topic>
<topic> comparison of short‐use potent versus prolonged‐use mild in childhood atopic dermatitis (Abstract)</topic>
<topic> topical</topic>
<topic> in acute radiation dermatitis</topic>
<topic> combination with lesional short‐contact dithranol therapy in psoriasis</topic>
<topic>cryoglobulinaemia, diffuse Bier white spots in (Correspondence)</topic>
<topic>cryotherapy, warts (Correspondence) 341 (Correspondence)</topic>
<topic>cutaneous lupus erythematosus</topic>
<topic> human Ro60 (SSA2) genomic organization and sequence alterations</topic>
<topic> lymphocytopenia as marker of systemic involvement (Concise Communication)</topic>
<topic>cyclic oligopeptides, effects on T cells (Abstract)</topic>
<topic>cyclophilin dynamics (Poster)</topic>
<topic>cyproterone acetate in female androgenetic alopecia</topic>
<topic>cytochrome P450 1A1 induction in mouse skin by UVB (Poster)</topic>
<topic>cytokeratin expression</topic>
<topic> pilonidal sinus</topic>
<topic> steatocystoma multiplex (Correspondence)</topic>
<topic>Darier's disease</topic>
<topic> ATP2A2 mutation analysis</topic>
<topic> genetic epidemiology</topic>
<topic> and Kaposi's varicelliform eruption (Correspondence)</topic>
<topic>decay accelerating factor aberrant expression in vitiligo</topic>
<topic>Denmark, nickel‐exposure regulation</topic>
<topic>dermal papilla cell oestrogen receptor expression (Poster)</topic>
<topic>dermatology nurse, effect of primary care consultation on quality of life of children with atopic dermatitis</topic>
<topic>dermatology teaching to medical students</topic>
<topic>dermatoscope, use for early identification of melanoma using three‐colour test (Concise Communication)</topic>
<topic>dermis</topic>
<topic> eNOS knockout mouse, apoptosis following UVB irradiation (Abstract)</topic>
<topic> in vivo microdialysis determination of IL‐6</topic>
<topic>desmosome adhesion regulation in wounded epidermis (Poster)</topic>
<topic>diabetes mellitus</topic>
<topic> autologous keratinocyte therapy of neuropathic foot ulcers (Poster)</topic>
<topic> and granuloma annulare (Concise Communication)</topic>
<topic> terbinafine therapy of toenail onychomycosis</topic>
<topic>diclofenac, topical treatment of actinic keratoses</topic>
<topic>diet and basal cell carcinoma</topic>
<topic>diphenylcyclopropenone, responses of peripheral blood mononuclear cells to (Abstract)</topic>
<topic>dithranol</topic>
<topic> combination of lesional short‐contact therapy with potent topical corticosteroid in psoriasis</topic>
<topic> induced tolerance in mouse ear oedema model</topic>
<topic> inflammation induced by, and phenotype (Poster)</topic>
<topic> inflammatory response to in non‐lesional psoriasis (Poster)</topic>
<topic>docetaxel</topic>
<topic> association with squamous syringometaplasia (Correspondence)</topic>
<topic> nail changes induced by (Correspondence)</topic>
<topic>drug allergy, blood test for confirmation (Abstract)</topic>
<topic>dyspareunia as sign of recurrence of glucagonoma (Case Report)</topic>
<topic>dystrophic epidermolysis bullosa, clinical spectrum</topic>
<topic>eccrine poroma (Clinical Cameo)</topic>
<topic>eczema see atopic dermatitis</topic>
<topic>EEC syndrome, prenatal diagnosis and p63 gene mutation</topic>
<topic>elastin receptor expression in perforating skin disorders</topic>
<topic>eNOS knockout mouse, dermal apoptosis following UVB irradiation (Abstract)</topic>
<topic>epidermal wounds, desmosomal adhesion regulation (Poster)</topic>
<topic>epidermodysplasia verruciformis with neurofibromatosis type 1 (Case Report)</topic>
<topic>Epstein–Barr virus</topic>
<topic> in blastoid nasal T/natural killer cell lymphoma (Case Report)</topic>
<topic> systemic lupus erythematosus induced by infection (Case Report)</topic>
<topic>erythema</topic>
<topic> facial, effects of nitric oxide inhibitors (Poster)</topic>
<topic> photo‐inducible mechanisms in clearance (Poster)</topic>
<topic> UV‐induced, and skin pigmentation (Poster)</topic>
<topic>erythema annulare centrifugum, calcipotriol therapy (Case Report)</topic>
<topic>erythema migrans, long‐term prognosis following treatment in France (Concise Communication)</topic>
<topic>erythromelalgia, treatment with serotonin/noradrenaline reuptake inhibitor (Correspondence)</topic>
<topic>etanercept</topic>
<topic> dermatological complications following therapy for rheumatoid arthritis (Correspondence)</topic>
<topic> in psoriasis and psoriatic arthritis (Concise Communication)</topic>
<topic>Euro, nickel release and contact dermatitis (Correspondence)</topic>
<topic>extracellular nucleotides, effect on HaCaT cells (Poster)</topic>
<topic>extracorporeal photopheresis, induction of apoptosis in graft‐versus‐host disease and cutaneous T‐cell lymphoma</topic>
<topic>eyelid swelling and breast cancer (Clinical Cameo)</topic>
<topic>facial telangiectasia, effects of nitric oxide inhibitors (Poster)</topic>
<topic>FcεRIα receptor expression by Langerhans cell in atopic dermatitis (Abstract)</topic>
<topic>fibrillin‐rich microfibrils, effects of acute UVB irradiation on (Abstract)</topic>
<topic>fibulin‐2 in dermis of photoaged skin (Correspondence)</topic>
<topic>fluoroquinolone antibiotics and photosensitization of thymine dimer formation in mouse skin (Abstract)</topic>
<topic>follicular adnexal tumours, differentiation between malignant and benign by DNA damage cytometry</topic>
<topic>follicular hamartoma with acrochordons, seborrhoeic keratoses and chondrosarcoma (Case Report)</topic>
<topic>folliculitis</topic>
<topic> with cutaneous larva migrans (Case Report)</topic>
<topic> sterile suppurative, associated with acute myeloblastic leukaemia (Case Report)</topic>
<topic>foot ulcers, diabetic neuropathic, autologous keratinocyte therapy (Poster)</topic>
<topic>free radicals in antigen formation</topic>
<topic>glomangioma, familial, basic fibroblast growth factor expression (Case Report)</topic>
<topic>glucagonoma, brittle nails and dyspareunia as signs of recurrence (Case Report)</topic>
<topic>gold acupuncture, pseudolymphoma induced by (Case Report)</topic>
<topic>graft‐versus‐host disease, induction of apoptosis by extracorporeal photopheresis</topic>
<topic>granuloma annulare</topic>
<topic> and diabetes mellitus (Concise Communication)</topic>
<topic> treatment with a 5‐lipoxygenase inhibitor and vitamin E (Case Report)</topic>
<topic>griseofulvin in tinea capitis</topic>
<topic>haemangioma, hobnail, nasal dorsum (Correspondence)</topic>
<topic>haematoma as complication of arterial Doppler studies (Correspondence)</topic>
<topic>haemophilia, acquired, and anti‐laminin 5 pemphigoid (Correspondence)</topic>
<topic>Hailey–Hailey disease, ATP2C1 gene mutation analysis</topic>
<topic>hair</topic>
<topic> darkening in porphyria cutanea tarda (Case Report)</topic>
<topic> density, diameter and female pattern loss (Correspondence)</topic>
<topic> growth promotion with procyanidin B‐2</topic>
<topic> melanins and melanocortin 1 receptor status (Abstract)</topic>
<topic>hairdressers, skin irritation thresholds</topic>
<topic>hair follicles, formation of cornified cell envelope in development</topic>
<topic>hairless gene in androgenetic alopecia</topic>
<topic>hand dermatitis</topic>
<topic> hairdressers</topic>
<topic> psychological factors</topic>
<topic>headache, dapsone‐induced, vitamin E therapy (Correspondence)</topic>
<topic>head lice resistance to pediculocides</topic>
<topic>heart, isolated amelanotic melanoma (Case Report)</topic>
<topic>heat shock protein</topic>
<topic> induction by sodium lauryl sulphate in human skin</topic>
<topic> upregulation in skin of patients with keratin gene mutations (Abstract)</topic>
<topic>heat shock protein</topic>
<topic>hepatitis C virus infection, cutaneous sarcoidosis during treatment for (Case Report)</topic>
<topic>Hermansky–Pudlak syndrome and systemic lupus erythematosus (Case Report)</topic>
<topic>HID syndrome and connexin 26 mutation</topic>
<topic>histamine, pruritogenic effects in mice (Abstract)</topic>
<topic>histiocytosis, progressive nodular, with hypothalamic tumour (Case Report)</topic>
<topic>HIV infection</topic>
<topic> cutaneous protothecosis in (Correspondence)</topic>
<topic> and Merkel cell carcinoma (Case Report)</topic>
<topic> regression of multiple warts following antiretroviral therapy (Clinical Cameo)</topic>
<topic>HLA alleles in Japanese pemphigus patients</topic>
<topic>hobnail haemangioma of nasal dorsum (Correspondence)</topic>
<topic>5‐HT, pruritogenic effects in mice (Abstract)</topic>
<topic>human papillomaviruses</topic>
<topic> carcinogenesis associated, loss of gap junctional intercellular communication (Abstract)</topic>
<topic> type</topic>
<topic>hyaluronic acid injection, arterial embolization following (Correspondence)</topic>
<topic>hydroperoxides, reduction of contact allergic response to by epidermal antioxidant treatment</topic>
<topic>hyperhidrosis, mesilate therapy (Correspondence)</topic>
<topic>hypertension and atopic dermatitis</topic>
<topic>hypothalamic tumour with progressive nodular histiocytosis (Case Report)</topic>
<topic>imiquimod in porokeratosis of Mibelli (Correspondence)</topic>
<topic>immune‐based therapies in psoriasis (Review)</topic>
<topic>immunotherapy, topical, viral warts (Correspondence)</topic>
<topic>infancy, malignant atrophic papulosis (Case Report)</topic>
<topic>inflammation</topic>
<topic> cutaneous antigen‐specific, CCR7 expression and role of apoptosis in resolution (Abstract)</topic>
<topic> dithranol‐induced, and phenotype (Poster)</topic>
<topic> role in progression of actinic keratoses to squamous cell carcinoma</topic>
<topic>infliximab in toxic epidermal necrolysis (Correspondence)</topic>
<topic>ING1 overexpression in human melanoma cell lines</topic>
<topic>interleukins</topic>
<topic> IL‐6, in vivo microdialysis determination in human dermis</topic>
<topic> IL‐8, effect on HaCaT cells (Poster)</topic>
<topic> IL‐10</topic>
<topic> inhibition of UVB‐induced expression by selenium compounds (Concise Communication)</topic>
<topic> production by DER p1‐specific T cells in atopic dermatitis (Abstract)</topic>
<topic> IL‐12, production by cells in mouse skin exposed to S. mansoni (Poster)</topic>
<topic>iodine, slow release preparations and wound healing</topic>
<topic>iron chelating agents, effects on photodynamic therapy (Abstract)</topic>
<topic>itch</topic>
<topic> experimental, in sodium lauryl sulphate‐inflamed and normal human skin</topic>
<topic> objective method to assay in childhood atopic dermatitis (Abstract)</topic>
<topic>itraconazole</topic>
<topic> long term results of therapy in onychomycosis</topic>
<topic> in yellow nail syndrome (Case Report)</topic>
<topic>ITT (Correspondence)</topic>
<topic>Kaposi's sarcoma, classic, virological status following chemotherapy/radiotherapy (Correspondence)</topic>
<topic>Kaposi's varicelliform eruption and Darier's disease (Correspondence)</topic>
<topic>keratin</topic>
<topic> characterization and regulation of type II hair‐specific genes (Abstract)</topic>
<topic> gene mutations and upregulation of small heat shock  protein (Hsp27) (Abstract)</topic>
<topic>keratinocytes</topic>
<topic> abnormal proliferation in molluscum contagiosum</topic>
<topic> autologous therapy in diabetic neuropathic foot ulcers (Poster)</topic>
<topic> cytotoxic effects of photodynamic therapy</topic>
<topic> HaCaT</topic>
<topic>  effects of IL‐8 and extracellular nucleotides on (Poster)</topic>
<topic>  inhibition of UVB‐induced apoptosis by NO synthase  antagonists (Abstract)</topic>
<topic>  MSH peptide signalling (Poster)</topic>
<topic> invasion by Staphylococcus aureus</topic>
<topic> regulation of caspase‐1 activity (Abstract)</topic>
<topic> selenium‐induced protection from chemical and UVR‐induced cell death (Abstract)</topic>
<topic> transcriptional regulation of activation in wound healing (Abstract)</topic>
<topic>KID syndrome and connexin mutation</topic>
<topic>Kikuchi's disease and SLE (Correspondence)</topic>
<topic>lactoferrin inhibition of Langerhans cell migration and TNF‐α production (Abstract)</topic>
<topic>laminin</topic>
<topic>Langerhans cells</topic>
<topic> effects of ageing on TNF‐α‐induced migration</topic>
<topic> expression of FcɛRIα receptor in atopic dermatitis (Abstract)</topic>
<topic> human epidermal migration and TNF‐α production following suction blister formation (Abstract)</topic>
<topic> lactoferrin inhibition of migration and TNF‐α production (Abstract)</topic>
<topic> regulation of migration (Poster)</topic>
<topic>larva migrans with folliculitis (Case Report)</topic>
<topic>laser capture microdissection of paraffin‐fixed skin sections (Poster)</topic>
<topic>laser therapy</topic>
<topic> one‐pass resurfacing</topic>
<topic> port‐wine stains</topic>
<topic>latex</topic>
<topic> contact anaphylaxis following use as hair extension adhesive (Correspondence)</topic>
<topic> type IV hypersensitivity reactions to</topic>
<topic>leflunomide in severe psoriasis and psoriatic arthritis (Correspondence)</topic>
<topic>lentigo maligna, radiotherapy</topic>
<topic>lentigo maligna melanoma, radiotherapy</topic>
<topic>leprosy, citric acid treatment of non‐healing ulcers (Clinical Cameo)</topic>
<topic>leukoplakia, oral, with cutaneous horn of the lips and palmoplantar keratoderma (Case Report)</topic>
<topic>lichen nitidus, treatment with antituberculous agent (Case Report)</topic>
<topic>lichen sclerosus, extragenital, topical calcipotriol therapy (Correspondence)</topic>
<topic>linear scleroderma, with muscle calcification (Case Report)</topic>
<topic>lipomatous mixed tumour of the skin (Case Report)</topic>
<topic>lips, cutaneous horn, with oral leukoplakia and palmoplantar keratoderma (Case Report)</topic>
<topic>loratidine, fixed drug eruption due to (Correspondence)</topic>
<topic>lupus anticoagulant and venous leg ulcers (Concise Communication)</topic>
<topic>lupus erythematosus tumidus, upregulation of epidermal surface molecule expression in UVR‐induced lesions</topic>
<topic>lupus vulgaris, diagnosis after 87 years (Correspondence)</topic>
<topic>lymphangioendothelioma, benign (Correspondence)</topic>
<topic>lymphocytopenia as marker of systemic involvement in cutaneous lupus erythematosus (Concise Communication)</topic>
<topic>lymphoedema with xanthomatosis, vaginal lymphorroea amd intestinal lymphangiectasia (Case Report)</topic>
<topic>lymphoma</topic>
<topic> B‐cell, presentation as recurrent angio‐oedema and molluscum contagiosum (Correspondence)</topic>
<topic> blastoid nasal T/natural killer cell, Epstein–Barr virus positive (Case Report)</topic>
<topic> cutaneous large B‐cell, similarity to chronic venous ulcer (Case Report)</topic>
<topic> cutaneous T‐cell</topic>
<topic> CD30+ with concurrent solid tumour (Case Report)</topic>
<topic> induction of apoptosis by extracorporeal photopheresis</topic>
<topic> lymphoblastoid natural killer‐cell (Case Report)</topic>
<topic> primary cutaneous B‐cell, absence of chromosomal translocation (Correspondence)</topic>
<topic> primary subcutaneous follicular centre cell, involvement of the galea (Case Report)</topic>
<topic> T‐zone with cutaneous involvement (Case Report)</topic>
<topic>lymphoma molluscatum (Correspondence)</topic>
<topic>male sexual dysfunction and thalidomide (Correspondence)</topic>
<topic>malignant atrophic papulosis in infancy (Case Report)</topic>
<topic>mastectomy, granulomatous lesions of homolateral limb following (Case Report)</topic>
<topic>medical students, dermatology teaching practices</topic>
<topic>melanin‐concentrating hormone receptor‐1 in vitiligo (Poster)</topic>
<topic>melanins, hair, and melanocortin</topic>
<topic>melanocortin 1 receptor</topic>
<topic> relationship of status to hair melanins (Abstract)</topic>
<topic> variants in melanoma cells (Abstract)</topic>
<topic> visualization (Poster)</topic>
<topic>melanoma</topic>
<topic> analysis of tumour site in relation to phenotopic traits and epidemiology</topic>
<topic> detection of atypical marginal melanocytes using Mohs' micrographic surgery</topic>
<topic> detection rate, self‐examination and clinical evaluation</topic>
<topic> ING1 overexpression in cell lines</topic>
<topic> isolated amelanotic of the heart (Case Report)</topic>
<topic> loss of catenin expression and disease progression (Correspondence)</topic>
<topic> melanocortin</topic>
<topic> serum S100</topic>
<topic>  concentrations and prediction of micrometastatic disease</topic>
<topic>  as marker in children (Correspondence)</topic>
<topic> tyrosinase, MIA and MART‐1 expression in sentinel lymph nodes</topic>
<topic> UK management guidelines</topic>
<topic> use of dermatoscope for early identification using three‐colour test (Concise Communication)</topic>
<topic>melasma</topic>
<topic> α‐MSH expression in lesional skin (Correspondence)</topic>
<topic> histopathology in Korean patients</topic>
<topic>membrane cofactor protein expression in vitiligo</topic>
<topic>Merkel cell carcinoma and HIV infection (Case Report)</topic>
<topic>mesilate in treatment of hyperhidrosis (Correspondence)</topic>
<topic>Microsporum gypseum, subcutaneous infection (Case Report)</topic>
<topic>minoxidil in female androgenetic alopecia</topic>
<topic>Mohs' micrographic surgery, detection of atypical melanocytes at margins of melanoma in situ</topic>
<topic>molluscum contagiosum</topic>
<topic> abnormal keratinocyte proliferation</topic>
<topic> as presenting sign of non‐Hodgkin's lymphoma (Correspondence)</topic>
<topic>morphoea profunda, TGF‐β3 expression analysis (Correspondence)</topic>
<topic>MSH peptide signalling in HaCaT keratinocytes (Poster)</topic>
<topic>mtDNA</topic>
<topic> histochemical and mutational analysis in tumours and matched normal human skin (Poster)</topic>
<topic> incidence of deletion and tandem duplications in sun‐exposed human skin (Abstract)</topic>
<topic>mycosis fungoides</topic>
<topic> familial (Correspondence)</topic>
<topic> mimicking granuloma annulare (Correspondence)</topic>
<topic>naevoid hypermelanosis, linear and whorled (Case Report)</topic>
<topic>naevus, melanocytic agminated plantar (Clinical Cameo)</topic>
<topic>nails</topic>
<topic> brittle, as sign of recurrence of glucagonoma (Case Report)</topic>
<topic> docetaxel‐induced changes (Correspondence)</topic>
<topic> involvement in pemphigus vulgaris</topic>
<topic> itraconazole therapy in yellow nail syndrome (Case Report)</topic>
<topic>nedocromil sodium, mechanism of inhibition of histamine‐induced itch and flare response (Abstract)</topic>
<topic>Netherton syndrome, genetic analysis and prenatal testing (Case Report)</topic>
<topic>neurofibromatosis type 1 with epidermodysplasia verruciformis (Case Report)</topic>
<topic>NFAT1 expression in psoriasis and inhibition in keratinocytes by cyclosporin A (Abstract)</topic>
<topic>nickel</topic>
<topic> contact dermatitis due to release from the Euro (Correspondence)</topic>
<topic> nickel‐exposure regulation in Denmark</topic>
<topic>nicotinic receptor cutaneous expression in palmoplantar pustulosis</topic>
<topic>nitric oxide inhibitors in facial erythema and telangiectasia (Poster)</topic>
<topic>nitric oxide synthase antagonist inhibition of UVB‐induced apoptosis of HaCaT keratinocytes (Abstract)</topic>
<topic>NOD2 gene, Crohn's syndrome‐associated insertion polymorphism (Poster)</topic>
<topic>non‐steroidal anti‐inflammatory drugs, hypersensitivity to in Blastocystis hominis infection (Correspondence)</topic>
<topic>notch4 gene and alopecia areata (Abstract)</topic>
<topic>occupational dermatitis caused by Pronematus davisi (Correspondence)</topic>
<topic>oestrogen receptor expression in human dermal papilla cells (Poster)</topic>
<topic>onychomycosis</topic>
<topic> and Candida</topic>
<topic> long term results of terbinafine and itraconazole therapy</topic>
<topic> terbinafine therapy in diabetes mellitus</topic>
<topic>onychopapilloma, as clinicopathological entity (Correspondence)</topic>
<topic>osteoma cutis with dysmorphic features (Case Report)</topic>
<topic>p14ARF mutational analysis in cutaneous squamous cell carcinoma (Poster)</topic>
<topic>p16INK4a mutational analysis in cutaneous squamous cell carcinoma (Poster)</topic>
<topic>p53 activation by UVB (Poster)</topic>
<topic>Paget's disease, extramammary, photodynamic therapy</topic>
<topic>palmoplantar keratoderma</topic>
<topic> epidermolytic, diagnosis and confirmation</topic>
<topic> hereditary focal transgressive (Case Report)</topic>
<topic> with oral leukoplakia and cutaneous horn of the lips (Case Report)</topic>
<topic>palmoplantar pustulosis, cutaneous nicotinic receptor expression</topic>
<topic>patch testing</topic>
<topic>dedicated clinic (Concise Communication)</topic>
<topic>frequency of reactions to topical antibiotics</topic>
<topic>patient satisfaction</topic>
<topic> indicators for assessment in patients with port‐wine stains</topic>
<topic> with teledermatology consultations (Abstract)</topic>
<topic>PCR nested assays, determination of mtDNA deletion in human skin (Poster)</topic>
<topic>pediculocide resistance in head lice</topic>
<topic>pemphigus</topic>
<topic> genotyping Japanese patients for HLA alleles</topic>
<topic> humanized SCID mouse model and autoimmunity to desmoglein‐3</topic>
<topic> nail involvement</topic>
<topic> paraneoplastic, in Castleman's disease (Correspondence)</topic>
<topic> transition to pemphigus foliaceus (Case Report)</topic>
<topic>pemphigus foliaceus, transition from pemphigus vulgaris (Case Report)</topic>
<topic>penciclovir dermal level measurement by cutaneous microdialysis (Abstract)</topic>
<topic>perineurioma</topic>
<topic> sclerosing bilateral (Case Report)</topic>
<topic> subungual (Case Report)</topic>
<topic>peripheral blood basophils, diurnal variation in chronic urticaria (Poster)</topic>
<topic>peripheral blood mononuclear cell responses to diphenylcyclopropenone (Abstract)</topic>
<topic>peroxiredoxin expression in dermatological disorders (Correspondence)</topic>
<topic>persimmon leaf extracts, oral administration in mouse model of atopic dermatitis</topic>
<topic>pharmacogenetics (Review)</topic>
<topic>photodynamic therapy</topic>
<topic> Bowen's disease (Poster)</topic>
<topic> cytotoxic effects on keratinocytes in vitro</topic>
<topic> effect on DNA base oxidation (Poster)</topic>
<topic> effect of iron chelating agent on (Abstract)</topic>
<topic> extramammary Paget's disease</topic>
<topic> in skin conditions other than non‐melanoma skin cancer (Review)</topic>
<topic> topical, guidelines</topic>
<topic>photopatch testing results from 10‐year period in Rotterdam</topic>
<topic>photosensitivity, persistent, following PUVA (Abstract)</topic>
<topic>phototype (Poster)</topic>
<topic>pigmentation and UV‐induced acute erythema response (Poster)</topic>
<topic>pigmented lesions, spectrophotometric intracutaneous analysis</topic>
<topic>pilonidal sinus, cytokeratin expression</topic>
<topic>pimecrolimus, topical, and skin atrophy (Correspondence)</topic>
<topic>plakophilin1, effect on keratinocytes in wound healing model (Abstract)</topic>
<topic>polyarteritis nodosa, cutaneous (Case Report)</topic>
<topic>porokeratosis of Mibelli, imiquimod therapy (Correspondence)</topic>
<topic>porphyria cutanea tarda, hair darkening in (Case Report)</topic>
<topic>port‐wine stains</topic>
<topic> indicators for assessment of quality of life and patient satisfaction</topic>
<topic> inheritance patterns (Poster)</topic>
<topic> laser therapy</topic>
<topic>pregnancy, acanthosis nigricans (Correspondence)</topic>
<topic>procyanidin B‐2, hair growth promotion</topic>
<topic>progressive nodular histiocytosis with hypothalamic tumour (Case Report)</topic>
<topic>Pronematus davisi, epidemic occupational dermatitis caused by (Correspondence)</topic>
<topic>Propionobacterium acnes, T‐cell mitogenic activity and inflammation in acne</topic>
<topic>protectin over‐expression in non‐lesional skin in SLE (Abstract)</topic>
<topic>protoporphyrin IX, correlation between cutaneous accumulation and transdermal 5‐aminolaevulinic acid delivery</topic>
<topic>protothecosis, cutaneous (Case Report)</topic>
<topic> in HIV infection (Correspondence)</topic>
<topic>pseudolymphoma induced by gold acupuncture (Case Report)</topic>
<topic>pseudopelade of Brocq, clinicopathological entities within (Correspondence)</topic>
<topic>psoriasis</topic>
<topic> anti‐E‐selectin therapy</topic>
<topic> chronic plaque</topic>
<topic> efficacy and safety of tacalcitol ointment</topic>
<topic> PSORS1 locus characterization (Abstract)</topic>
<topic> cognitive–behavioural symptom management programme as adjunct to therapy</topic>
<topic> combination of lesional short‐contact dithranol therapy with potent topical corticosteroid</topic>
<topic> etanercept therapy (Concise Communication)</topic>
<topic> expression and regulation of cytoprotective genes in skin by UVR (Abstract)</topic>
<topic> generalized pustular and erythrodermic, association with bupropion treatment (Case Report)</topic>
<topic> laminin1 distribution in skin</topic>
<topic> leflunomide therapy (Correspondence)</topic>
<topic> NFAT1 expression (Abstract)</topic>
<topic> non‐lesional, inflammatory response to dithranol and sodium dodecyl sulphate (Poster)</topic>
<topic> novel immune‐based therapies (Review)</topic>
<topic> quality of life</topic>
<topic> recruitment of S. pyogenes‐specific T cells to lesions (Abstract)</topic>
<topic> relapse pattern (Poster)</topic>
<topic> TGF‐β1 polymorphisms (Poster)</topic>
<topic> topical treatment (Review)</topic>
<topic>psoriatic arthritis</topic>
<topic> etanercept therapy (Concise Communication)</topic>
<topic> leflunomide therapy (Correspondence)</topic>
<topic>PSORS1 gene in chronic plaque psoriasis (Abstract)</topic>
<topic>PUVA</topic>
<topic> maintenance therapy in atopic dermatitis (Correspondence)</topic>
<topic> persistent skin photosensitivity following (Abstract)</topic>
<topic>pyoderma gangrenosum</topic>
<topic> as presentation of sarcoidosis (Correspondence)</topic>
<topic> vegetative, in chronic renal failure (Case Report)</topic>
<topic>quality of life</topic>
<topic> in atopic dermatitis</topic>
<topic> in children with atopic dermatitis</topic>
<topic> indicators for assessment in patients with port‐wine stains</topic>
<topic> in psoriasis</topic>
<topic>radiation dermatitis, acute, topical corticosteroid therapy</topic>
<topic>radiotherapy, lentigo maligna and lentigo maligna melanoma</topic>
<topic>Rotterdam, results from10‐year period of photopatch testing</topic>
<topic>S100 protein, serum levels as marker of melanoma in children (Correspondence)</topic>
<topic>sarcoidosis</topic>
<topic> during treatment of HCV infection (Case Report)</topic>
<topic> presentation with pyoderma gangrenosum (Correspondence)</topic>
<topic> subcutaneous (Correspondence)</topic>
<topic>scalp</topic>
<topic> arrector pili proximal attachment variant in terminal follicles (Concise Communication)</topic>
<topic> pigmented nodules (Clinical Cameo)</topic>
<topic>Schistosoma mansoni, production of IL‐12 by cells in mouse skin exposed to (Poster)</topic>
<topic>scleroderma, linear, with muscle calcification (Case Report)</topic>
<topic>sclerotherapy, effects on subclinical primary antiphospholipid syndrome (Correspondence)</topic>
<topic>screening for skin cancer (Review)</topic>
<topic>selenium</topic>
<topic> inhibition of UVB‐induced IL‐10 expression (Concise Communication)</topic>
<topic> protection of keratinocytes from chemical and UVR‐induced cell death (Abstract)</topic>
<topic>serotonin/noradrenaline reuptake inhibitor in erythromelalgia (Correspondence)</topic>
<topic>severe cutaneous adverse reactions, time latency between beginning of drug use and onset of reaction (Abstract)</topic>
<topic>sexual dysfunction and thalidomide (Correspondence)</topic>
<topic>Singapore, prevalence and epidemiology of atopic dermatitis in school children</topic>
<topic>skin cancer, screening and surveillance (Review)</topic>
<topic>skin irritation</topic>
<topic> differences between Japanese and European women</topic>
<topic> proteomic analysis</topic>
<topic>smoking, effect on collagen synthesis and extracellular matrix turnover in human skin</topic>
<topic>sodium dodecyl sulphate, inflammatory response to in non‐lesional psoriasis (Poster)</topic>
<topic>sodium lauryl sulphate</topic>
<topic> experimental itch in human skin inflamed by</topic>
<topic> induction of Hsp27 in human skin</topic>
<topic>sonic hedgehog signal transducer expression by basal cell carcinoma</topic>
<topic>spectrophotometric intracutaneous analysis of pigmented lesions</topic>
<topic>squamous cell carcinoma</topic>
<topic> cutaneous, mutational analysis of p16INK4a and P14ARF (Poster)</topic>
<topic> primary cutaneous, multiprofessional management guidelines</topic>
<topic> role of inflammation in progression of actinic keratoses to</topic>
<topic>squamous syringometaplasia associated with docetaxel (Correspondence)</topic>
<topic>Staphylococcus</topic>
<topic> T cell responses to (Abstract)</topic>
<topic> virulence mechanisms in human keratinocytes</topic>
<topic>steatocystoma multiplex, cytokeratin expression (Correspondence)</topic>
<topic>Still's disease, adult, serum caeruloplasmin level (Case Report)</topic>
<topic>stratum corneum, effects of rehydration on UV sensitivity</topic>
<topic>suction blisters, Langerhans cell human epidermal migration and TNF‐α production following formation (Abstract)</topic>
<topic>sun‐exposed human skin, mtDNA deletion and tandem duplications (Abstract)</topic>
<topic>sunscreens</topic>
<topic> benefits of daily use in the UK (Concise Communication)</topic>
<topic> and immune protection (Review)</topic>
<topic>surveillance for skin cancer (Review)</topic>
<topic>Sweet's syndrome, lymphocytic infiltrates as presenting feature (Case Report)</topic>
<topic>systemic lupus erythematosus</topic>
<topic> and Hermansky–Pudlak syndrome (Case Report)</topic>
<topic> induced by Epstein–Barr virus infection (Case Report)</topic>
<topic> and Kikuchi's disease (Correspondence)</topic>
<topic> protectin over‐expression in non‐lesional skin (Abstract)</topic>
<topic>tacalcitol efficacy and safety in chronic plaque psoriasis</topic>
<topic>tacrolimus</topic>
<topic> liposomal, in immune‐mediated skin disorders</topic>
<topic> topical, and skin atrophy (Correspondence)</topic>
<topic>T cells</topic>
<topic> effects of cyclic oligopeptides derived by phage display (Abstract)</topic>
<topic> responses to Staphylococcus (Abstract)</topic>
<topic> sensitized, detection in drug‐allergic patients (Abstract)</topic>
<topic> S. pyogenes‐specific, recruitment to psoriasis lesions (Abstract)</topic>
<topic>telangiectasia, facial, effects of nitric oxide inhibitors (Poster)</topic>
<topic>teledermatology consultation, patient satisfaction (Abstract)</topic>
<topic>telomerase activity correlation with telomeres in cutaneous melanocytic lesions</topic>
<topic>telomere evaluation in cutaneous melanocytic lesions and correlation with telomerase activity</topic>
<topic>terbinafine</topic>
<topic> long term results of therapy in onychomycosis</topic>
<topic> in refractory chromoblastomycosis (Clinical Cameo)</topic>
<topic> therapy of toenail onychomycosis in diabetes mellitus</topic>
<topic> in tinea capitis</topic>
<topic>thalidomide and male sexual dysfunction (Correspondence)</topic>
<topic>thioredoxin expression in dermatological disorders (Correspondence)</topic>
<topic>thymine dimers, effects of fluoroquinolone antibiotics on formation in mouse skin (Abstract)</topic>
<topic>tinea capitis, study of oral terbinafine and high‐dose griseofulvin</topic>
<topic>toxic epidermal necrolysis, infliximab therapy (Correspondence)</topic>
<topic>transforming growth factors</topic>
<topic> expression in morphoea profunda (Correspondence)</topic>
<topic> polymorphisms in psoriasis (Poster)</topic>
<topic> triamcinolone</topic>
<topic> intralesional therapy in chondrodermatitis nodularis (Correspondence)</topic>
<topic> in phytocosmetic cream (Correspondence)</topic>
<topic>tuberculosis, cutaneous, biochemical and histochemical changes pertaining</topic>
<topic>tumour necrosis factor‐α, influence of ageing on Langerhans cells migration induced by</topic>
<topic>ultraviolet radiation</topic>
<topic> effects of stratum corneum rehydration on sensitivity to</topic>
<topic> expression and regulation of cytoprotective genes in skin of psoriasis patients (Abstract)</topic>
<topic> guidelines for dosimetry and calibration in therapy</topic>
<topic> UVB</topic>
<topic> cell cycle effects and p53 activation (Poster)</topic>
<topic> contribution of VEGF to angiogenic response</topic>
<topic> dermal apoptosis following irradiation in eNOS knockout mouse (Abstract)</topic>
<topic> effect of acute irradiation on fibrillin‐rich microfibrils (Abstract)</topic>
<topic> induction of antinuclear and anti‐Ro/SSA antibodies in female nod mice following irradiation (Abstract)</topic>
<topic> induction of cytochrome P450 1A1 in mouse skin (Poster)</topic>
<topic>urticaria, chronic</topic>
<topic> in Blastocystis hominis infection (Correspondence)</topic>
<topic> diurnal variation in peripheral blood basophils (Poster)</topic>
<topic> natural history</topic>
<topic>vaccination with recombinant vaccinia virus in vulval intraepithelial neoplasia (Abstract)</topic>
<topic>vascular endothelial growth factor (VEGF), contribution to angiogenic response upon UVB irradiation in vivo</topic>
<topic>venous leg ulcers</topic>
<topic> and cholesterol embolism (Correspondence)</topic>
<topic> and lupus anticoagulant (Concise Communication)</topic>
<topic>vernix caseosa, epidermal barrier lipids</topic>
<topic>vitamin D3 in refractory chromoblastomycosis (Clinical Cameo)</topic>
<topic>vitamin E in dapsone‐induced headache (Correspondence)</topic>
<topic>vitiligo</topic>
<topic> aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor</topic>
<topic> melanin‐concentrating hormone receptor‐1 (Poster)</topic>
<topic>vulval intraepithelial neoplasia, vaccination trial (Abstract)</topic>
<topic>warts</topic>
<topic> cryotherapy (Correspondence)</topic>
<topic> oral zinc sulphate therapy</topic>
<topic> regression in HIV infection following antiretroviral therapy (Clinical Cameo)</topic>
<topic> topical immunotherapy (Correspondence)</topic>
<topic>weal and flare reaction, laser‐induced</topic>
<topic>wet wrap dressings in atopic dermatitis (Correspondence)</topic>
<topic>wound healing</topic>
<topic> effect of plakophilin 1 on keratinocytes (Abstract)</topic>
<topic> slow release iodine preparations</topic>
<topic> transcriptional regulation of keratinocyte activation (Abstract)</topic>
<topic>wounds, epidermal, desmosomal adhesion regulation (Poster)</topic>
<topic>xanthomatosis with lymphoedema, vaginal lymphorroea amd intestinal lymphangiectasia (Case Report)</topic>
<topic>yellow nail syndrome, itraconazole therapy (Case Report)</topic>
<topic>zinc sulphate, oral therapy in recalcitrant viral warts</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>British Journal of Dermatology</title>
</titleInfo>
<genre type="journal">journal</genre>
<identifier type="ISSN">0007-0963</identifier>
<identifier type="eISSN">1365-2133</identifier>
<identifier type="DOI">10.1111/(ISSN)1365-2133</identifier>
<identifier type="PublisherID">BJD</identifier>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>146</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>6</number>
</detail>
<extent unit="pages">
<start>1133</start>
<end>1141</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">06575D9CFA43C3148A6BCDF7138AD5B7E364A5EF</identifier>
<identifier type="DOI">10.1046/j.1365-2133.2002.t01-1-01466.x</identifier>
<identifier type="ArticleID">BJDBJD_V146_I6_KWDINDEX</identifier>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Blackwell Science Ltd</recordOrigin>
</recordInfo>
</mods>
</metadata>
<author></author>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000300 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000300 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:06575D9CFA43C3148A6BCDF7138AD5B7E364A5EF
   |texte=   Subject Index
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024